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Cardiovascular diseases are the major cause of death worldwide and represent a 
dramatic socio-economic challenge. Hypertension accounts for 18% of 
cardiovascular disease deaths in the Western countries, and is a major risk factor 
for stroke, coronary heart disease and heart failure. Excessive dietary salt intake 
is known to be a risk factor for developing hypertension, but the pathophysiology 
of salt sensitive hypertension is poorly understood. The kidneys are the main 
regulators of Na+ and water in the body. Salt sensitive hypertension has 
traditionally been explained by an impaired capacity of the kidneys to excrete 
Na+, resulting in water retention and thereby a progressive alteration in the filling 
of the vasculature, resulting in increased blood pressure. Recent studies have 
suggested that Na+ can be retained or removed from the body without 
commensurate water, and that the skin may function as sodium reservoir. It has 
been shown that the Na+ accumulation is controlled by immune cells and 
involves modification of the extracellular matrix and lymphangiogenesis in the 
skin. In this thesis we therefore addressed three major questions to clarify aspects 
of the new hypothesis proposing the skin as a contributor to Na+ and blood 
pressure homeostasis; 1) What are the microcirculatory effects of increased 
lymphatic vasculature in the skin, 2) are new lymph vessels induced by Na+ 
retention functional, and 3) does lymphatic vasculature in the skin affect Na+ 
accumulation and blood pressure homeostasis. 
To study the microcirculatory effects of a chronically expanded lymphatic 
vasculature in the skin we used K14-VEGF-C mice overexpressing vascular 
endothelial growth factor-C (VEGF-C), resulting in an expanded lymphatic 
network in skin. Acute and chronic inflammation resulted in increased interstitial 
fluid pressure and reduced lymph flow, but to the same extent in transgenic mice 
and WT controls. However, after local overhydration in the skin we observed 
increased lymph flow and fluid transport in the transgenic mice. Despite 
increased production of the immune cell chemoattractant CCL21 in K14-VEGF-
C mice, local inflammation did not result in an increased number of migrating 
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immune cells from the skin to the draining lymph node. We concluded that 
lymphangiogenesis might enhance clearance of fluid in situations with increased 
fluid filtration. 
Sodium accumulation in the skin is suggested to be regulated by macrophages 
that secrete VEGF-C in response to a hyperosmotic microenvironment thereby 
stimulating lymphangiogenesis. An important question is whether these newly 
formed vessels are functional. After salt loading in rats we measured lymph flow 
in skin and muscle with optical imaging and a newly developed PET-CT method. 
Increased lymph flow was observed in skin as well as muscle. A reduction of 
lymph flow was observed after macrophage depletion in the skin. Our findings 
suggest that newly formed lymphatic vessels are functional, and that 
macrophages may be involved in the regulation of lymph flow and thereby 
clearance of Na+ from tissues. 
Previous studies have shown that mice lacking lymphatics in the skin develop 
higher blood pressure after salt loading. To address the question whether 
lymphatic vasculature in skin is important for Na+ accumulation and blood 
pressure homeostasis, we used genetically engineered mice with either increased 
or reduced lymphatic vasculature in the skin. Blood pressure was measured with 
telemetric recording before salt loading and at the termination of the experiment. 
Tissue samples from skin and muscle were harvested for analysis of Na+ and K+ 
concentration. We found no differences in Na+ accumulation or blood pressure 
response between genetically engineered mice and normal controls. Our results 
suggest that lymphatic vasculature in skin does not have an important role in 
electrolyte and blood pressure homeostasis in mice.  
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High blood pressure or hypertension is a major risk factor for developing 
cardiovascular diseases and kidney failure, and is ranked as the leading risk 
factor for premature deaths in the world. Worldwide over 1 billion people have 
high blood pressure, and it has been estimated that 9 million people die every 
year of diseases that are directly linked to hypertension (1). 
The relationship between high blood pressure and risk of certain diseases has 
been known since the 18th century, but it was uncertain whether reducing blood 
pressure was useful in disease prevention. In 1932 Johan Hay stated that “the 
greatest danger to man with high blood pressure lies in its discovery, because 
then some fool is certain to try and reduce it” (2). Today the knowledge of the 
importance of lowering an elevated blood pressure to reduce the risk of 
developing diseases is undisputed (3).  
Genetics, race, age, gender and behavioural (e.g. smoking, physical inactivity, 
unhealthy diet) are all factors that are known to predispose individuals for 
developing hypertension (4). Importantly, a reduction in dietary salt intake has 
been shown in several studies to lower blood pressure in individuals with 
hypertension (5).  
In the 1960s Guyton et al. introduced the classical view on how salt affects the 
blood pressure. They stated that hypertension is the result of impaired excretion 
of sodium in the kidneys, which leads to a higher blood pressure to maintain the 
sodium excretion, so called pressure natriuresis (6). Here the kidneys were 
identified as the main regulators of long term blood pressure (7). This hypothesis 
has been discussed over the years, and it seems clear that the complex 
mechanisms that lead to hypertension are not exclusively found in the kidneys, 
but also involve other organ systems.  
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Titze et al. have shown in studies with mice, rats and humans that salt can be 
stored in the body without commensurate water and that the skin can be a 
reservoir for sodium (8-10). These findings have led to the hypothesis that skin 
might contribute as an extrarenal regulator of the sodium homeostasis in the 
body. This salt accumulation model seems to involve remodelling of the 
lymphatic network and activation of immune cells in the skin. Inhibition of the 
immune cells in the skin after salt loading appears to increase blood pressure 
(11-13).   
In the introduction to my thesis I will briefly discuss the physiology of blood 
pressure and the pathophysiology that might lead to hypertension. The lymphatic 
system, the interstitium and the immune system, with a focus on the anatomy 
and function within the skin, will be described. Towards the end of the 
introduction I will discuss the role of sodium in fluid volume homeostasis in the 
body and present elements that seem to be central in the new model of salt 
storage in the skin. 
1.2 Blood pressure 
Arterial blood pressure (ABP), hereafter referred to as blood pressure, is an 
important clinical parameter. Because it is easy and fast to measure and gives 
important information about patient health, blood pressure is one of the most 
frequently used clinical parameters. Blood pressure is given with two values, a 
systolic blood pressure (SBP) and a diastolic blood pressure (DBP), where SBP 
is the pressure in the arteries during heart contraction and DBP is the pressure 
when the heart is relaxing.  
1.2.1 Blood pressure regulation  
In the simplest sense, blood pressure is defined as the product of two factors; 
cardiac output (CO) and total peripheral resistance (TPR):  ABP = CO x TPR.  
CO depends on the total blood volume in the vasculature, the contractility 
volume and heart rate, whereas TPR is determined by the contractile state of the 
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small arteries and arterioles and the viscosity of the blood (14). In the body there 
are many systems that regulate these factors and they work together in a complex 
way. The kidneys, nervous system and vasculature together with different 
hormonal regulators are all important contributors in blood pressure homeostasis 
(15). Two physiological systems that play an important role in this regulation are 
the renin-angiotensin-aldosterone system (RAAS) and the autonomic nervous 
system (ANS) (16, 17). 
The RAAS is important for sodium and volume balance and thereby blood 
pressure regulation in the body. The enzyme renin is released from the kidneys 
in response to different stimuli, such as reduced perfusion pressure in the afferent 
arterioles of the kidney and low concentration of sodium and chloride in the 
tubule system in the kidney (18). Renin cleaves angiotensinogen, which is 
synthesized primarily in the liver, to the biologically inactive substrate 
angiotensin 1 (ANG I).  ANG I is further cleaved to angiotensin 2 (ANG II), the 
main effector peptide of the RAAS, by the enzyme angiotensin-converting 
enzyme (ACE) which is found in different organs in the body and is particularly 
abundant on the surface of endothelial cell in the lungs (19). Via activation of 
the receptor angiotensin II Type 1 (AT1), ANG II elicits most of the functions of 
the RAAS such as vasoconstriction, water retention and aldosterone production 
(20). Aldosterone is a mineralocorticoid that mainly regulates renal sodium 
retention in the kidneys, whereby an increased secretion of aldosterone leads to 
increased intravascular volume (21).  
Baroreceptors that sense changes in blood pressure are located in various places 
in the arterial vasculature, a central location being the carotid sinus (14). These 
receptors sense when an increased blood pressure stretches the blood vessel wall, 
leading to nerve impulse messages to the brain and decrease of the sympathetic 
activity of the ANS and thereby lowering blood pressure (22).  
By producing different vasoactive substances, vascular endothelial cells are also 
major contributors to blood pressure regulation (23). Nitric oxide (NO), being 
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the most important of these substances, is produced and released continuously 
by vascular endothelial cells in response to changes in shear stress induced by 
the blood flow (24). NO is a gas and once it is synthesized in the endothelial cell, 
it diffuses into the smooth muscle that surrounds blood vessels where it activates 
enzymes that produce substrates that reduce the tension of the smooth muscle 
(25). 
1.2.2 Hypertension 
Hypertension occurs when the pressure in the arteries is persistently elevated. 
Normal blood pressure in an adult is defined as a systolic blood pressure of 120 
mmHg and a diastolic pressure of 80 mmHg. New guidelines from the American 
Heart Association define hypertension as an average SBP≥130mmHg or an 
average DBP≥80 (26). It is expected that these new guidelines will increase the 
prevalence of individuals diagnosed with hypertension by 14% compared with 
the old guidelines (average SBP≥140mmHg or an average DBP≥90). 
In 90-95 % of patients with hypertension the cause of the elevated blood pressure 
is unknown, so-called idiopathic or essential hypertension (4). Hypertension 
caused by other medical conditions is termed secondary hypertension. 
Conditions that can lead to elevated blood pressure are diseases in the kidneys, 
heart, blood vessels and endocrine system. These underlying conditions are often 
correctable, and the blood pressure will normalize when patients are treated (27). 
Further discussion in this thesis will focus on essential hypertension. 
1.2.3 Pathophysiology of hypertension  
Since there are many systems involved in blood pressure regulation, the 
pathophysiological abnormalities associated with essential hypertension are also 
complex. Despite intensive research in the area of hypertension spanning several 
decades and new understanding of cellular and molecular biology, the 
pathophysiology is still poorly understood. Figure 1 shows some of the main 




Figure 1. Organ systems involved in the pathophysiology of hypertension.  
As discussed earlier is the RAAS important for blood pressure regulation. 
Impaired capacity of the kidneys to excrete fluid and sodium because of 
abnormalities in the RAAS seems to play an important role in hypertension, and 
ACE inhibitors and angiotensin receptor blockers are important drugs for 
treatment (28). Interestingly, kidney transplantation from a hypertensive animal 
(Dahl hypertensive rat), into a normotensive animal resulted in the development 
of hypertension in the normotensive animal (29). This indicates that the kidneys 
might have intrinsic functions that are important for development of 
hypertension. 
In hypertension, the control of the ANS can be impaired, leading to an increase 
in activity in the sympathetic nervous system (SNS) which regulates the heart 
and peripheral vessels (30). The increased activity in SNS is relevant for both 
acute increases in blood pressure as well as the development of a persistently 
elevated blood pressure. Studies in patients with hypertension where SNS 
activity is measured with microneurography have shown that increasing levels 
of SNS activity correlate with increasing severity of hypertension (31, 32). The 
plasma concentration of norepinephrine, a catecholamine that is an important 
neurotransmitter in the SNS, is also found to be elevated in patients with 
hypertension (33).  
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Endothelial dysfunction generally refers to a diminishing endothelium-
dependent vasodilatation (34). In hypertension, endothelial dysfunction is 
caused by a combination of mechanical pressure-induced damage and 
augmented oxidative stress causing vascular endothelial inflammation. 
Increased production of reactive oxygen species (ROS) and decreased activity 
of antioxidants, such as the enzyme superoxide dismutase in endothelial cells, 
leads to accumulation of ROS (35). The ROS bind to NO and thereby reduce the 
availability of NO. NO promotes vascular relaxation, and decreased availability 
is a central factor in endothelial dysfunction and hypertension (36) (37).  
The immune system might also play a central role in the pathophysiology of 
hypertension and this will be discussed further in the immune system section 
below.  
1.3 The Lymphatic system 
The first description of the lymphatic system is from the ancient Greek time, 
where Hippocrates refers to it as “white blood”, but it was not until the 17th 
century that the lymphatic vascular system was characterized. By the early 19th 
century the anatomy of the lymphatic system was almost fully characterized, but 
there were still new discoveries to be made. For a long time it was believed that 
there was no lymphatic drainage system in the central nervous system (CNS), 
but with the discovery of functional lymphatic vessels in the meninges (38) (39) 
and in the eyes (40) it appears that the lymphatic system also contributes to fluid 
homeostasis in the CNS. New and more specific markers like LYVE-1, 
podoplanin, and Prox-1 have given a better understanding of the function and 
organization of the lymphatic system (41).  
The lymphatic system is a part of the vascular system and is a one-way transport. 
It is responsible for collecting excess fluid and proteins from the interstitial space 
and draining it back to the venous system, and therefore performs an important 
role in fluid homeostasis in the body. It is also an important route for transport 
of immune cells to the lymph nodes where immune responses are initiated. The 
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lymphatic system can be divided into two different tissue types, the lymphatic 
vasculature and lymph nodes. Lymph nodes are lymphoid tissue and will be 
discussed more in detail under the immune system section 1.5. below. 
1.3.1 Lymphatic vasculature 
The lymphatic vasculature is an open system and can be divided into four 
different types of lymphatic vessels; the lymphatic capillaries, pre-collecting 
vessels, collecting vessels and the bigger trunks and ducts (Figure 2). 
Lymphatic capillaries are found in the interstitium and are the start of the 
lymphatic vasculature and they are therefore also referred to as initial 
lymphatics. These vessels are blind-ended and have a diameter between 10-60 
μm (42). The branched organization of the lymphatic capillaries makes them able 
to cover a large surface area in the interstitium. The vessel wall is built up of a 
single layer of partly overlapping lymphatic endothelial cells (LECs) with an 
indistinct defined basement membrane (43). The organization and structure of 
the vessels leads to efficient absorption of fluid from the interstitium. 
Fluid from the capillaries drain into the pre-collecting vessels and further to the 
collecting vessels.  The collecting vessels are larger and are covered with a layer 
of circular smooth muscle. The lymphatic vascular endothelium has a continuous 
basement membrane and between the LECs there are zipper-like junctions that 
prevent leakage of lymph (44). Inside the vessels there are regularly distributed 
valves that avert retrograde flow and ensure unidirectional lymph flow from the 
periphery back to the venous circulation. These valves also form chambers inside 
the vessels, and together with the circular smooth musculature that surrounds the 
vessel, these chambers form a functional contractile unit called a lymphangion. 
Lymphangions can contract independently or in a coordinated contraction 
pattern with other lymphangions upstream and downstream (45). The 
coordinated contraction pattern facilitates effective transport of fluid toward the 
venous circulation against a pressure gradient caused by gravity. All collecting 
vessels pass through lymph nodes and are divided into prenodal and postnodal 
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collecting vessels. The prenodal or afferent vessels drain into lymph nodes, and 
multiple lymphatic vessels can drain into the same lymph node. The postnodal 
or efferent vessel exits the lymphatic node, and there is usually only one efferent 
vessel that exits the node. Lymph nodes and immune cell migration to the lymph 
nodes will be discussed further in the section 1.5. on the immune system below. 
 
Figure 2. Lymphatic capillaries start as blind endings and are built up of partially overlapping 
LECs. Precollector lymphatic vessels are partially covered with smooth muscle cells, and 
LECs form zipper-like junctions to prevent leakage. Precollectors drains into collecting 
vessels that are covered with circular smooth muscle. Valves inside the vessels form 
chambers that to together with the circular smooth muscle form lymphangions. DCs migrate 
to lymphatic capillaries via a process driven by CCL21 chemokines.   
The postnodal collecting vessels drain to trunks and ducts. These are larger 
vessels where the structure is similar to the collecting vessels. The trunks drain 
fluid from the most proximal lymph nodes into the thoracic duct and the right 
lymphatic duct. These ducts are the last vessels in the lymphatic vasculature 
before they drain into the venous circulation, respectively into the left subclavian 




The fluid transported by the lymphatic system is called lymph. Lymph is formed 
from interstitial fluid when it drains into the lymphatic capillaries. Interstitial 
fluid (IF) is the ultrafiltrate from blood capillaries in the microcirculation and is 
found in the interstitial space. IF plays an important role in transport of nutrients 
to and waste products from the cells, signalling molecules to and from the cells 
and of antigens and cytokines to the lymphatic vasculature (47). The hydrostatic 
pressure inside the capillaries and the osmotic pressure that occurs because of 
different composition of proteins and electrolytes in plasma and the interstitial 
fluid provide a low level of fluid filtration over the entire length of the capillaries 
toward the interstitial space (48, 49).  This accumulation of IF will result in an 
increase in interstitial fluid pressure (Pif) that serves as driving force for fluid 
toward the initial lymphatics where lymph is produced. Initial lymph and IF is 
considered to have equal composition (47).  
Lymph is the product of the ultrafiltrate of plasma and consists of various plasma 
proteins, cytokines, electrolytes, macromolecules, immune cells and antigens 
(50). The composition of lymph compared to plasma has been debated for 
decades. It was long thought that the protein composition would be similar with 
that of plasma, and that albumin and serum globulins made up most of the 
proteins in lymph.  But lymph analysed with proteomics methods has indicated 
that there are differences in protein expression between lymph and plasma (51, 
52). The major differences are the finding of proteins from the extracellular 
matrix in the lymph (e.g. glycoproteins, collagen, proteoglycans and laminins) 
and proteins that are specific to the parenchymal organ from which lymph drains 
(53, 54). 
The concentration of electrolytes in lymph compared to plasma has also been 
discussed.  There have been studies with conflicting results regarding the 
concentration of Na+, K+ and Cl-. Some studies have found no difference in the 
electrolyte composition of IF compared to plasma (55) and some a higher 
concentration of Na+ and K+ and a lower concentration of Cl- (56). Technical 
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problems associated with the cannulation of the smaller lymphatic vessels as 
well as the small volume of lymph and IF collected that make the samples prone 
to evaporation, might be reasons for the conflicting results. 
1.3.3 Lymph flow 
 The transport of lymph includes both its formation and flow in the initial 
lymphatic vasculature and the flow thorough the larger collecting lymphatic 
vessels. As mentioned earlier, the formation of lymph is a consequence of fluid 
in the interstitial space, whereby Pif is an important factor for filling the initial 
lymphatics (57). A rise in Pif has been shown to increase lymph flow, which in 
turn reduces Pif back towards to normal level (58). When the volume of newly 
formed lymph inside the initial lymphatic vessels rises, the lymph will flow 
downstream to the larger collecting vessels. 
In the collecting vessel a combination of intrinsic and extrinsic factors regulate 
the lymph flow. The extrinsic factors are due to mechanical forces from the 
surrounding tissue acting on the lymphatic vasculature that thereby facilitate 
lymph flow. Skeletal muscle movement, negative pressure in the thoracic cavity 
during inspiration, vasomotion of blood vessel nearby and the suction effect from 
the blood flow in nearby large veins, are examples of such extrinsic mechanical 
forces (59). 
The collecting vessels, as briefly described before, consist of lymphangions, 
which are contractile units with muscle on the outside and valves inside (45). 
Lymphangions are the intrinsic factor that regulates lymph flow in the collecting 
lymphatics. They propel lymph forward by contractions of the muscle 
surrounding the vessel, making each lymphangion act like a small heart. These 
contractions lead to a decrease in the diameter of the colleting vessel, which 
increases the pressure inside the vessel and thereby facilitates lymph flow 
downstream (60).  
The regulation of the contractility of lymphangions is not well understood. Like 
the ventricles in the heart, lymphangions contract cyclically and the volume of 
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lymph pumped is dependent on preload, afterload, contractility and the 
frequency of the contractions (61). Lymphatic muscle cells (LMCs) surrounding 
the lymphatic vessels have similar characteristics to both cardiac and vascular 
muscle. LMCs have shown to express isoforms of actin and myosin filaments 
that contract coordinated and rhythmically. Electrophysiological experiments 
have shown that the contractions are preceded by action potentials generated by 
spontaneous depolarization that is created by electrical pacemaker activity (62, 
63). This spontaneous pacemaker function can be modulated by different factors 
like temperature, shear stress and signal molecules and proteins. Additionally, 
interstitial osmolarity changes due to an increase or decrease in Na+ and Cl- have 
shown to affect the frequency of contraction of the lymphangions and thereby 
lymph flow (64).  
1.3.4 Lymphangiogenesis 
The term lymphangiogenesis is used to describe the growth of the initial 
lymphatic vasculature, the development of new lymphatic vessels from pre-
existing lymphatic vasculature and the hyperplasia of existing vasculature.  
At the beginning of the 20th-century the American anatomist Florence Sabin 
advocated that primitive lymphatic vessels originate from venous endothelial 
cells (65). Based on dye injection experiments, she showed that LECs originate 
from veins in embryonic pigs and later form patterns of dense lymphatic 
vasculature in tissue and organs. During the 20th-century it was debated whether 
LECs originated exclusively from veins or if there also were embryonic cells 
that could develop into LECs independently from veins. By the end of that same 
century it was postulated that lymphangioblasts were present in the embryonic 
mesenchyme (66), but it was not until 2015 that two independent research groups 
found the convincing evidence of a non-venous origin of LECs (67, 68). In adult 
tissue new lymphatic vasculature is generated from pre-existing lymphatic 
vessels and hyperplasia of existing vasculature. Inflammation is an important 
cause of lymphatic remodelling and lymphangiogenesis in adulthood (69).  
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Vascular endothelial growth factors (VEGFs) are signalling molecules that are 
important in the development and regulation of the lymphatic system, both in 
embryonic and adult tissue (70). VEGFs bind to vascular endothelial growth 
factor receptors (VEGFRs), and the VEGF/VEGFR signalling pathway has over 
the past decades emerged as the principal driver of angiogenesis, both for 
lymphatic vasculature and blood vessels. The VEGFs are a family consisting of 
five different molecules that includes VEGF-A, VEGF-B, VEGF-C, VEGF-D 
and placenta growth factor (PlGF). The VEGFR family consists of three different 
receptors: VEGFR-1, VEGFR-2 and VEGFR-3, each giving different outcomes 
when activated (71).  VEGF-C-induced activation of VEGFR-3 is shown to be 
the prime signalling mechanism for lymphangiogenesis, both during embryonic 
development and in adult life (72) (73). A soluble form of VEGFR-3 (sVEGFR-
3) that inactivates VEGF-C has been found, and experiments in genetically 
modified mice expressing sVEGFR-3 in the skin have shown inhibition of 
lymphatic vessel growth and development of lymphoedema in the skin (74). In 
mice overexpressing VEGF-C in the skin, the dermal lymphatic vascular 
network is enlarged (75).  
In the embryonic stage VEGFR-3 is expressed in all vascular endothelial cells, 
but in adult life it is mainly expressed on the surface of LECs (76). Activated 
macrophages have also been found to express VEGFR-3 (77) which might play 
an important role in inflammation-induced lymphangiogenesis (78). 
Experiments have also shown that macrophages migrate to the skin of rodents 
after increased salt intake, indicating that they might be important for the 
regulation of sodium homeostasis in the skin (11). Macrophages may secrete 
VEGF-C and stimulate lymphangiogenesis in the skin. Depletion of the migrated 
macrophages in rats has been shown to reduce both the secretion of VEGF-C and 
lymphangiogenesis, leading to a change in sodium regulation in the skin and 




Skin is the organ with the largest surface area in the body and it makes up around 
15 % of the body weight (79). It is crucial for maintaining normal homeostasis 
in the body; e.g. preventing fluid loss, help regulating body temperature and is 
important for sensory inputs.  The skin is also an important immune organ. It 
forms a physical barrier, and employs both biomolecules and immune and non-
immune cells, to protect the rest of the body against microorganisms and other 
harmful substances (80). The skin is commonly divided in three layers; 
epidermis, dermis and hypodermis. (Figure 3).  
The epidermis is the outmost layer of the skin and is a stratified structure of five 
different layers comprised primarily of keratinocytes. The stratum corneum is 
the outermost layer of epidermis and serves as a shielding overcoat due to 
keratinization and lipid content. The stratum lucidum consists of immortalized 
cells, which are only found in the skin of palms and soles. The stratum 
granulosum contains several cell layers and as the keratinocytes move outward 
in these layers, they begin to lose their nuclei. The stratum spinosum is the 
thickest layer in the epidermis and also consists of several cell layers. Here 
keratinocytes are connected by desmosomes, which allow them to be tightly 
bound to each other. The stratum basalis is the innermost layer and closest to the 
dermis. It consists of a single row of keratinocytes that evolve and mature as they 
migrate to the outer layers of the epidermis (81). The stratum basalis also 
contains stem cells and melanocytes, the latter producing melanin and thereby 
being responsible for our skin colour (82). There are also immune cells in 
epidermis, and these will be explored further in the section 1.5.1 entitled 




Figure 3. Cross section of the three layers of the skin; epidermis, dermis and hypodermis. 
 
The dermis is the layer below the epidermis and the two layers are separated by 
a basement membrane. The basement membrane is comprised of extracellular 
matrix proteins that make a thin and tight sheet that regulate the migration of 
cells and the movement of proteins between the dermis and epidermis (83). The 
dermis is cell poor and is primarily made up of connective tissue that gives 
structure and elasticity to the skin. Fibroblasts are the primary cells found in the 
dermis, and they produce extracellular matrix elements such as collagen, elastin 
and glycosaminoglycans (GAGs). Histocytes, mast cells, macrophages and 
adipocytes are found in the dermis and they contribute in maintaining the 
function and structure of the dermis. Blood vessels, lymphatic vessels, nerve 
endings, glands and hair follicles are other structures important for the function 
of the dermis (84).  
The hypodermis or subcutaneous tissue is the deepest layer of the skin. It is 
largely made up of adipose tissue and is connected to deep fascia (85). 
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1.4.1.  The extracellular matrix of the skin 
The interstitium is defined as the space between the vasculature and the cells 
(57). Its basic structure consists of a fibre framework of mainly collagen, a 
homogenous gel phase consisting of GAGs, different cells and a fluid phase 
derived from plasma containing plasma proteins and electrolytes (8) (Figure 4). 
The extracellular matrix (ECM) is the non-cellular component of the interstitium 
and is a well-organized network that provides physical support for tissues. The 
ECM is most prominent in the dermal layer of the skin where it is involved in 
the regulation of several cellular processes involving migration, growth, 
homeostasis and differentiation (86).  
 
Figure 4. The basic structure of the interstitium showing different cells, proteins and fibre 
framework. Modified from Wiig ((87).  
 
The fibre framework of the ECM is, as mentioned, mainly built up of collagen. 
Collagen is a large family of ECM proteins and account for 20-30% of total body 
proteins (88). Twenty-nine different types of collagen have been described and 
they are classified into different sub-types according to structural similarity and 
organization of macromolecules (89).  In dried skin, collagen fibres account for 
almost 70% of the weight of the dermis. Other fibrous-forming proteins that also 
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make up the framework of the ECM are elastin, fibronectin and laminins. Elastin 
has more elastic properties than collagen and constitutes 2-4% of the dermis, 
where it contributes to the elasticity of the skin (90). 
The other major structural constituents of the extracellular matrix are GAGs. 
GAGs are long linear polysaccharide molecules that are classified into six 
different types depending on the disaccharide molecule group (91). GAGs are 
negatively charged and therefore have a high water-holding capability. This 
water holding capability makes GAGs important for mechanical and space-
filling functions and for the regulation of tissue water content in the skin (92). 
Hyaluronan (HA) is the most abundant GAG in the ECM of the skin and due to 
its coil structure it is able to hold about 1000-fold of its own molecular weight 
in water (93). 
The ECM is a very dynamic structure that is constantly undergoing remodelling 
and repair, which is important to maintain a normal function and tissue 
homeostasis. Fibroblasts are crucial in this process with coordinated secretion of 
enzymatic and non-enzymatic regulators (94). Different proteases are involved 
in remodelling, but the major proteases are considered to be the matrix 
metalloproteinases (MMPs) (95). MMPs are primarily synthesized in fibroblasts 
and also immune cells such as monocytes and macrophages, but also endothelial 
cells have been observed to express genes for MMPs (96). Abnormal ECM 
remodelling occurs in different diseases and pathological processes like 
inflammation, leading to loss of structure and change in the composition of the 
ECM (97, 98). It has been suggested that negatively charged GAGs, which make 
up the gel phase of the extracellular matrix in the skin, might store sodium and 
hence be involved in the sodium homeostasis in the body (8, 11, 99). 
1.5 Immune system 
The traditional view of the immune system is that it provides protection from 
harmful invading microorganisms. The basic framework in this model is that 
antigen from invading microorganisms is taken up by immune cells that present 
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the antigen to other immune cells, which leads to an immune reaction against the 
harmful invaders (100). Over the last few decades it has also been revealed that 
the immune system has other fundamental roles beyond that of protection against 
invading microorganisms (100). It is an important part of physiological 
processes like wound healing and remodelling of organs during development and 
disease (101-104). It is also evident that the immune system and other 
physiological systems in the body such as metabolism, the central nervous and 
the cardiovascular system work closely together to maintain organ and body 
homeostasis (105-107). Further details about the immune system in the skin and 
the role of the immune system in hypertension will be discussed in the upcoming 
sections.   
1.5.1 Immune cells in skin 
A variety of different immune cells are localized in the various layers of the skin. 
In the epidermis are Langerhans cells (LCs), which are members of the dendritic 
cell family, the main antigen-presenting cells (APC). From the early 
development, the LCs form a dense network in the basal layer of the epidermis 
with dendritic processes that extends out to the other layers in the epidermis 
(108). During inflammation, LCs capture antigens and migrate through the 
basement membrane to the dermis before they enter the lymphatic vasculature 
and are transported to the nearest lymph node (109).   
There are several types of immune cells found in the dermis, including mast 
cells, lymphocytes, neutrophils, macrophages, monocytes and dermal dendritic 
cells (dDC). Unlike the epidermis, the structure of the ECM permits free 
migration of immune cells within the dermis (82). Monocytes, macrophages and 
dDC are part of the mononuclear phagocyte system (MPS), a specialized family 
of phagocytes that are important for innate immunity and phagocytic processes 
(110). New research indicates that the MPS also play an important role in skin 
homeostasis like wound healing, tissue repair and stress response (111, 112). 
Depletion of macrophages during inflammatory processes has shown additional 
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consequences such as reduced vascularisation and reduced expression of growth 
factors like VEGF-A and VEGF-C (12, 113). 
1.5.2 Lymph nodes 
All lymph produced in the interstitial space is transported to regional lymph 
nodes before it is returned back into the venous circulation. Lymph nodes are 
small and bean-shaped organs enclosed by a capsule strategically located along 
the lymphatic vasculature (114).  They are lymphoid organs that contain large 
amount of lymphocytes and APCs like macrophages and DCs. It is in the lymph 
node that the adaptive immune system is exposed to new antigens and the 
immune response towards antigens is initiated (115).   
1.5.3 Immune cell migration from the skin to the lymph node 
In addition to the transport of lymph, the lymphatic vasculature is also important 
for immune cell migration to lymph nodes. Of the MPS cells, it is the DCs that 
are specialized in migrating to lymph nodes, other MPS cells might also have 
migratory capabilities but they are generally regarded as non-migratory (116). 
DCs crawl through the interstitial space with help of fluid channels created by 
IF that is being pushed toward the lymphatic capillaries (117). Upon activation, 
the DCs upregulate the C-C chemokine receptor type 7 (CCR7), which helps 
guide the DCs towards the lymphatic capillaries by binding to the chemokine 
(C-C motif) ligand 21 (CCL21) that is expressed on the LECs (118) (Figure 2).  
CCL21 is stored in intracellular compartments in LECs and is under normal 
conditions released constitutively in low concentrations to maintain normal 
homeostasis in the skin (119). During inflammatory conditions or mechanical 
stimuli, such as an augmented lymph flow, the secretion of CCL21 is increased, 
which promotes DCs migration to the lymph node (120, 121). Mice lacking 
lymphatic vessels in the dermis have reduced DCs migration and an impaired 
immune response (122).  
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1.5.4 The immune system and hypertension 
Accumulating evidence indicates that low-grade inflammation might play an 
important part in the development and maintenance of hypertension, however 
the mechanisms involved are unclear (123). Studies have shown that immune 
cells harvested from rats with hypertension after unilateral renal artery clipping 
and deoxycorticosterone (DOCA) combined with salt diet, induced hypertension 
when injected into normotensive rats (124, 125). It has also been shown that mice 
lacking B and T cells were protected against DOCA and salt induced 
hypertension, but restored sensitivity to the development of hypertension after 
replenishment of T-cells (126). The role of T-cells in hypertension is not clear.  
It has been reported that in hypertensive mouse models, T-cells infiltrated 
regions of the brain that control sympathetic outflow and that T-cell activation 
is enhanced (127, 128). T-cells are observed to be a contributor in endothelial 
dysfunction and microvascular remodelling and rarefaction (126, 129). In the 
kidneys, T-cell infiltration might alter function and thereby lead to increased 
retention of sodium and water (130). 
As a part of the adaptive immune system, T-cells require antigens presented by 
APCs to be fully activated (131). Some of the most potent APCs are the DCs 
with their high expression of the molecule major histocompatibility complex 
class II (MHC II), which is important for the presentation of antigen to the T-
cells (132). It is not clear what role DCs have in T-cell activation when it comes 
to the development of hypertension.  In a hypertension model in mice involving 
angiotensin II infusion, the expression of the cell marker CD86, a costimulatory 
molecule needed for activation of lymphocytes, increased on dendritic cells 
(133). Mice with reduced capability to express CD86 had less activated T-cells 
and did not get the same increase in blood pressure as normal mice (133). The 
antigens that might be involved are not known. Hypertension models like DOCA 
and salt or angiotensin II infusion in rodents, leads to increased production of 
reactive oxygen species, which in turn lead to cell damage, lipid oxidation and 
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production of molecules that are suggested to act as antigens or neoantigens in 
the activation of T-cells by DCs (134-136). 
It seems clear that no single immune cell type, pathway or mechanism mediate 
the immune reaction that leads to hypertension. It is more likely that different 
immune cells and pathways in different organs are activated and that each 
reaction communicates with its surroundings to activate additional immune 
responses or directly influence mechanisms that are important in blood pressure 
regulation. 
1.6 Sodium 
In an adult person water makes up 60% the total body weight and it is divided 
into two main compartments; two-thirds being intracellular and one-third being 
extracellular water (137). Body water contains different substances like 
electrolytes, metabolites and proteins. Of the electrolytes, sodium and potassium 
are the major cations and chloride the major anion. The composition of 
electrolytes is different between the intracellular and extracellular fluid. Sodium 
is the major cation in extracellular fluid whereas potassium has this role in 
intracellular fluid (138). Sodium is osmotically active, and the regulation of 
sodium is tightly linked to the water balance in the body and thereby the 
homeostasis of extracellular fluid volume. The normal range of sodium in the 
extracelluar fluid is 135-145 mmol/L and the maintenance of a normal 
extracellular osmolality and fluid volume is critical for normal body homeostasis 
(139).  
The kidneys are the main regulator of electrolytes and water in the body, and 
they are also important for the acid-base balance, the production of the hormone 
erythropoietin that facilitates the production of red blood cells and in the 
excretion of different metabolic waste products and toxins (140).  Of the 
approximately 200-litres of fluid that is filtrated through the kidney per day, 99% 
is reabsorbed as the fluid passes along the tubules. Sodium is reabsorbed through 
the entire length of the tubule system in a very energy-consuming process and 
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the final concentration of sodium in the urine varies depending on water and salt 
intake (141).  
1.6.1 Sodium and blood pressure 
There are many studies linking a high dietary salt intake and hypertension, and 
reducing dietary salt intake has been shown to reduce blood pressure (142-144). 
Nevertheless, there is a substantial variation in blood pressure response between 
individuals after increased dietary salt intake, with some demonstrating an 
increase in blood pressure while others show no effect, a phenomenon referred 
to as salt sensitive and salt resistant individuals (145). 
The factors that explain the association between increased dietary sodium intake 
and hypertension are not completely understood. More than 30 years ago Guyton 
and colleagues developed the “pressure natriuresis” model to demonstrate how 
dietary salt intake affects the blood pressure. This model suggested that the 
kidneys increase sodium excretion in response to increased blood pressure, 
thereby reducing the blood volume and returning blood pressure back to normal 
(146). If the capacity of the kidneys to excrete salt is reduced, the BP will 
increase over time to a new and higher level at which intake and output of salt 
will be in balance. This model places the kidneys at the very centre of how long-
term sodium and water regulation lead to hypertension (7).  
1.6.2 Sodium and the skin 
New data from long-term observational studies in humans have shown that 
considerable amounts of sodium could be retained or removed from the subjects 
without commensurate water retention or loss (147-149). These data led to the 
proposal of an alternative model suggesting that osmotically inactive sodium 
could be stored somewhere in the body and that sodium concentration within the 
interstitial fluid does not necessary equilibrate with the sodium concentration in 
the intravascular compartment (56, 150). By measuring sodium and water 
content in the skin of rats given a high salt diet, studies have revealed that the 
skin might serve as major reservoir and a buffer for excess sodium, and that the 
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skin microenvironment is hypertonic compared to plasma (9, 151, 152). Studies 
using 23Na+-magnetic resonance imaging (MRI) have suggested that sodium 
accumulation in the skin not only occurs in rodents, but also in humans (10, 153). 
When comparing normotensive and hypertensive patients there was a correlation 
between skin sodium and BP; patients with resistant hypertension had increased 
sodium accumulation in the skin compared to normotensive patients (153). 
 
Figure 5. Skin sodium accumulation model suggested by Titze and colleagues. Modified from 
Coffman (15).  
The hypertonic microenvironment caused by salt storage in the skin, is proposed 
to create osmotic stress that activates the transcripton factor tonicity-responsive 
enhancer-binding protein (TonEBP) in MPS cells (11, 12). In vitro experiments 
have shown that a high concentration of extracellular sodium can be a 
chemoattractant for macrophages and that they migrate actively toward a salt-
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induced hypertonic area (154). MPS cells infiltrate the hypertonic interstitium 
and induce TonEBP driven VEGF-C expression (11). VEGF-C induces 
lymphangiogenesis and restructures the lymphatic capillary network in the 
interstitium, which seems to be important for the regulation of tissue sodium and 
systemic blood pressure (Figure 5). Blocking VEGF-C signalling or depletion of 
macrophages has, in animal models, been shown to result in reduced density of 
the lymphatic vasculature and reduced accumulation of sodium in the skin, again 




The kidneys are the main regulator of water and electrolytes in the body, but 
based on the new data presented above; additional local extrarenal regulation of 
electrolytes in skin might contribute to maintaining normal extracellular 
electrolyte homeostasis and blood pressure. There are several important 
questions that can be raised by this model and thus need to be pursued further. 
In particular the composition and remodelling of the interstitium and the 
functional consequences thereof are of interest. In this thesis I therefore had the 
following aims: 
 
 To investigate whether hyperplastic and chronically expanded lymph 
vessels in the skin are functional (Paper I). 
 
 To study whether lymph vessels formed after salt accumulation in the skin 
are functional and affect lymph flow (Paper II).  
 
 To investigate how blood pressure regulation, lymphatic function and 
sodium accumulation are affected during salt loading in mice that either 






In this section I will present the main methods used in paper I-III. For a more 
detailed description and protocols I refer to Materials and Methods in the 
respective papers. Methodological considerations will be addressed in the 
“Discussion” section. 
3.1 Animal models 
In this project, both rat and mouse models have been essential. All animals were 
exposed to light on a 12:12-h cycle in a humidity- and temperature- controlled 
environment. Only male rats and mice were used in this project. 
NTac Sprague Dawley rats were purchased from Møllegård Breeding Colony, 
Skensved, Denmark. (Paper II) 
C57 BL/6 mice were purchased from Jackson Laboratories.  (Paper II) 
Chy mice on C3H background were obtained from MRC-Harwell Institute. 
These mice have a heterozygous mutation in the gene coding for the vascular 
endothelial growth factor receptor 3 (VEGFR-3), resulting in a phenotype with 
a hypoplastic lymphatic network in the dermis but not in the visceral organs 
(155). WT littermates were used as controls. (Paper III) 
K14-VEGFR-3-Ig mice on C57BL/6 background were provided by Dr. Kari 
Alitalo, Helsinki, Finland. K14-VEGFR-3-Ig mice produce soluble VEGFR-3 in 
the skin under the keratin-14 promoter. Soluble VEGFR-3 binds and inactivates 
VEGF-C, resulting in a phenotype that lacks lymphatic vasculature in the dermis 
(156). WT littermates were used as controls. (Paper III). 
K14-VEGF-C mice on FVB background were provided by Dr. Kari Alitalo, 
Helsinki, Finland. K14-VEGF-C mice express VEGF-C in the skin under the 
keratin-14 promoter, which gives a phenotype with hyperplastic lymph vessels 
in the skin (75). WT littermates were used as controls. (Paper I and III) 
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3.2 Inducing high blood pressure 
Two different models were used to induce high blood pressure in the rodents; 
the High-Salt-Diet model (HSD) and the DOCA-Salt model. 
High-Salt-Diet: Rats and mice received chow containing 8% and 4% NaCl, 
respectively, and 1% saline to drink for 2 weeks. 
DOCA-Salt: A slow-release deoxycorticosterone acetate (DOCA) tablet (50 mg 
in mice and 100 mg in rats, Innovative Research of America) was implanted 
subcutaneously in the animal. Under isoflurane anaesthesia, a small surgical 
incision was made caudally on the cranial back skin region and with blunt 
dissection a subcutaneous tunnel was made to the cranial back skin region. The 
tablet was inserted through the tunnel in a plastic catheter to protect the tablet 
before it was lodged at the end of the tunnel. The animals were given 1% saline 
as drinking water and normal chow to eat for 2 weeks. Blood pressure was 
measured before the start and at termination of the experiment. 
As a control we used a low salt diet (LSD) as well as regular chow considered 
as normal salt diet (NSD). Low salt chow contains less than 0.1% salt and regular 
chow 0.5% salt. Both control groups had normal tap water to drink. 
3.3 Blood pressure measurements  
We used two different methods to measure blood pressure in the animals. The 
measurements in rats were done with the tail-cuff method and in mice we used 
telemetric recording. 
Tail-cuff 
The CODA-6 tail-cuff system for rodents (Kent Scientific, Torrington, CT) was 
used for all blood pressure measurements in rats. The tail-cuff system detects 
volume changes in the tail due to changes in the blood flow with a volume-cuff 
after occlusion and gradual reduction of the pressure of the tail artery with an 
occlusion-cuff. Blood pressure was measured before the start and at the 
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termination of the experiment. The rats were preheated in an incubator at 34°C 
before measurements. The animals were awake and kept inside a restrainer 
during blood pressure measurements.   
Telemetric recording 
We used the PA-C10 telemetry implant from Data Sciences International (DSI) 
to measure blood pressure in mice. The implant consists of a transmitter with a 
catheter filled with gel. The transmitter converts pressure pulses from the 
catheter to radio waves that are detected by a receiver. A computer connected to 
the receiver transforms the radio waves to physiological data, such as blood 
pressure and heart rate (157). Before implantation the mice were anaesthetized 
with isoflurane. A midline incision on the ventral side of the neck was made and 
the left carotid artery was dissected free and ligated at the carotid bifurcation. 
The catheter of the transmitter was advanced towards the heart through a small 
incision in the wall of the carotid artery, so that the tip of the catheter was a few 
millimetres inside the aortic arch. The transmitter was placed subcutaneously on 
the left flank. Absorbable sutures were used to close the midline incision in the 
skin. The mice were given buprenorphine subcutaneously (0.1 mg/kg) for pain 
relief after the operation. After a minimum of 10 days recovery, baseline blood 
pressures were measured in freely moving mice.   
3.4 Lymph flow in skin and muscle 
Optical imaging was used to measure lymph flow in the skin of rats and mice. 
To measure lymph flow in the deeper positioned muscles in rats we used positron 
emission tomography – computer tomography (PET-CT). 
Optical imaging 
In the skin and skeletal muscle, large macromolecules will only be removed with 
the lymph (47). With optical imaging we measured the lymph flow indirectly by 
monitoring the clearance of intradermally injected albumin that was labelled 
with a near-infrared dye (158). With a Hamilton syringe (34G needle), 0.5 and 3 
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μl Alexa 680-conjugated bovine serum albumin was injected into the skin of the 
hind paw of rats. At different time points, the skin was scanned using the Optic 
MX optical scanner, and the intensity of the fluorochrome was measured. The 
decrease in intensity over time, as albumin was washed out, was used to estimate 
the clearance of albumin, which is an indirect estimate of the lymph flow. During 
scanning the animals were anesthetized with 2% isoflurane. In the periods 
between scans the rats were awake and freely moving to facilitate lymph flow. 
PET-CT 
The principle for measuring lymph flow in muscle with PET is similar to optical 
imaging in skin.  Instead of labelling the albumin with a near-infrared dye, we 
used the PET-emitter 124I. The radionuclides are absorbed at a lower extent in 
tissues than fluorescent probes and can be used to estimate lymph flow in deeper 
positioned tissue. Albumin was conjugated with 124I, which has a half-life of 4.18 
days. The conjugated albumin was injected into thigh muscles and the rats were 
scanned in the PET-CT at different time points to measure the decrease in 
radioactivity. The rats were freely moving in between scans.   
3.5 Flow cytometry 
Flow cytometry is a laser-based analysis technique used for the characterization 
and detection of cells. We used the technique to quantify immune cell migration 
from skin to the draining lymph node in mice. Eighteen hours after their ears 
were painted with fluorescein isothiocynate (FITC) solution (FITC 8mg/ ml in 
1:1 acetone and dibutyl phthalate), the mice were sacrificed and the draining 
lymph nodes harvested. The lymph nodes were incubated with collagenase D 
and filtered through a 70 μm cell strainer. The cell suspension was incubated 
with antibodies (CD45, CD11c and MHC II) and a live/dead marker (7AAD). 
The cell suspension was analysed using a BD LSR Fortessa Cytometer. 
Migrating dendritic cells were characterized as FITC+ CD11c+ MHC II++ CD45+ 




Immunohistochemistry is a semi-quantitative method that we used to identify 
lymphatic and blood vessels, chemokines and immune cells in dermis. We 
prepared tissue samples for immunohistochemistry in three different ways: 
Whole mount staining was used to quantify the amount of lymphatic and blood 
vessels and the chemokine CCL21 in ears. Freshly cut ears were harvested after 
the animals had been sacrificed. Hair was removed with depilatory cream and 
they were fixed overnight in 4% PFA at 4°C and thereafter washed and stored in 
PBS. The ears were split in half and the dorsal part was mounted with needles to 
a Sylgaard plate prepared with silicon in the bottom. The ears were then washed 
with 0.3% PBS-TritonX before adding blocking solution with 5% serum from 
the same species as the secondary antibodies were raised in to reduce unspecific 
binding and background fluorescence. A mixture of primary antibodies in the 
blocking solution was added and the ears were incubated for 3 days at 4°C.  They 
were then washed with 0.3% PBS-TritonX overnight incubation with 
fluorescently labelled secondary antibodies at 4°C. After incubation with 
secondary antibodies, the ears were washed properly once again before being 
post-fixed with 4% PFA for 5 minutes followed by washing with PBS. The ears 
were then mounted to microscope slides and analysed with fluorescence 
microscopy. Quantification was preformed using QuPath and/or ImageJ by 
selecting 3-5 different areas from each ear, which expressed suitable staining 
without signs of tissue damage after preparation.  
Epidermal sheets staining was used to quantify the number of Langerhans cells 
in the epidermis of mice. Freshly cut ears from sacrificed mice were split in half 
after hair removal. The dorsal part of the ears, with the inner dermis side faced 
down, were placed in a well containing 0.5M ammonium thiocyanate for 40 
minutes at 37°C. With fine forceps the epidermis was peeled off and fixed for 20 
minutes in ice-cold acetone. After fixation, the sheets were repeatedly washed 
with PBS before being blocked with 5% serum from the same species as the 
secondary antibodies were raised in.  The sheets were incubated for 2 hours with 
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the same blocking solution containing antibodies against Langerhans cells 
(CD207 and MHC II). After several washes with 0.3% PBS-TritonX, the sheets 
were incubated with fluorescent-labelled secondary antibodies for 1 hour. After 
washing the sheets, they were mounted on microscope slides and analysed with 
fluorescence microscopy. Quantification was preformed using ImageJ by 
selecting 3-5 areas from each sheet, which expressed suitable staining without 
sign of tissue damage after preparation. 
Serial section staining was performed to quantify the number of lymphatic 
vessels and immune cells in the dermis of rats and mice. Frozen 4% PFA fixed 
tissue sections and snap-frozen tissue samples were used to quantify lymphatic 
vessels in the dermis, while paraffin sections were used to quantify immune cells.  
The detailed protocol on how the different staining methods were performed on 
serial sections can be found in the individual papers.  
3.7 Chemical analysis of tissue electrolytes 
Two different methods were used to determine the concentration of different 
electrolytes in the tissue:   
High performance liquid chromatography (HPLC) is a chromatographic 
technique used to identify, quantify or purify different molecules (i.e. protein, 
nucleic acids, electrolytes) of a mixture. A liquid mixture is run through a 
column that shows selective absorption for different solutes in the mixture. 
HPLC use high pressure to push the liquid through the column, which makes it 
much faster than ordinary column chromatography that uses gravity as driving 
force.  By measuring the time that different molecules use to pass through the 
column to the detector, it is possible to determine the type and amount of 
molecules in the mixture. Samples from skin and muscle were collected upon 
termination of the experiment. Wet weight (WW) of the samples was measured 
before desiccation in a drying chamber. After 1 week of drying to obtain stable 
weight, the dry weight (DW) of the tissue samples was measured. Tissue water 
content was calculated as the difference between WW and DW. The dried 
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samples were eluted in ultrapure water (Milli-Q, Millipore Corporation) for 1 
week, so that the added water would to equilibrate with the electrolyte 
concentration of the dried sample.  After spinning the eluted sample, 50 μl of the 
eluate was analysed for sodium and potassium by HPLC-based ion 
chromatography.  
Ashing is a method where dried tissue is ashed at 190°C and 450°C for 24 hours 
at each temperature level, and then at 600°C for 48 hours. Ashed tissue is then 
dissolved in 5% or 10% HNO3. We measured the concentration of electrolytes 





4. Summary of the results 
4.1 Paper 1: Lymhangiogenesis Facilitates Initial Lymph Formation and 
Enhances the Dendritic Cell Mobilizing Chemokine CCL21 Without 
Affecting Migration 
In this paper we studied the functional consequences of an expanded lymphatic 
network in the skin. We showed that K14-VEGF-C mice that overexpress 
VEGF-C in skin have an expanded cutaneous lymphatic network with a changed 
morphology. Blood vessels appeared to have a normal morphology and the 
number of blood vessels was the same in both VEGF-C and WT littermate mice. 
The chemokine CCL21, which is expressed on lymphatic endothelial cells and 
acts as an attractant for dendritic cells, was overexpressed in VEGF-C mice. The 
dendritic cell numbers in the epidermis were similar in VEGF-C and WT mice. 
Despite the overexpression of CCL21 found in VEGF-C mice, dendritic cell 
migration from the skin to the draining lymph node was not enhanced. Total 
tissue water (TTW) and Pif in the skin were the same in both strains during 
control conditions, and there was also no difference in capillary permeability and 
lymph low, indicating a normal capillary barrier. We observed an increase in 
TTW and Pif as well as reduced lymph flow after inducing chronic inflammation 
with topically applied oxazolone and acute inflammation with 
lipopolysaccharide injections. These findings were the same in VEGF-C and WT 
mice. The VEGF-C mice demonstrated enhanced lymph flow after local 
overhydration not induced by inflammation, suggesting that lymphangiogenesis 





4.2 Paper 2: High-Salt Diet Causes Expansion of the Lymphatic Network 
and Increased Lymph Flow in Skin and Muscle of Rats 
Based on previous studies where salt accumulation in the skin has been shown 
to lead to VEGF-C secretion and lymphangiogenesis, we asked if this had any 
effect on lymphatic function. We found that rats in the HSD and DOCA group 
had an increased number of lymphatic vessels in the dermis of the ear. By using 
optical imaging to measure washout of fluorescently labelled albumin from the 
skin, we found a moderate increase in lymph flow in the HSD and DOCA group 
compared with LSD controls. The same results were also observed in skeletal 
muscle during HSD when recording lymph flow using PET-CT. HSD and 
DOCA did not affect transcapillary filtration, indicating that the capillary barrier 
was unaffected during salt loading. Lymph flow was significantly reduced after 
depletion of skin monocytes/ macrophages with clodronate in the skin, indicating 
that these cells might be involved in the lymph flow response observed in the 
HSD and DOCA groups. To further study whether a hyperosmotic environment 
has an effect on the function of lymphatic vessel pumping, we isolated skin 
lymphatic vessels and exposed these to a solution made hyperosmotic by adding 
Na+ while measuring contractility. The lymphatic vessels increased their 





4.3 Paper 3: No evidence for a role of lymphatics in skin in electrolyte and 
blood pressure homeostasis in mice 
To address the question of whether the lymphatic network in the skin has a 
functional role in electrolyte and blood pressure homeostasis, we exposed 
genetically engineered mice that either had a hypoplastic (Chy), hyperplastic 
(VEGF-C), or completely lacked (VEGFR3-Ig) lymphatic network in the dermis 
to salt loading. As controls we used WT littermates. The mice were given either 
HSD or DOCA, and blood pressure was measured with telemetric recording 
before, and at termination of the experiment. Skin was harvested to perform 
electrolyte concentration analysis with HPLC. For quantification of 
lymphangiogenesis, whole mount staining of lymphatic vessels in ears was 
performed. There were no differences in sodium content in the skin between the 
genetically engineered and control mice before start of the experiment, when the 
mice were fed NSD. Baseline blood pressure was the same in Chy and VEGF-C 
mice compared to WT controls, while VEGFR3-Ig had slightly lower blood 
pressure.  HSD did not increase blood pressure in any of the mouse models, and 
there was no accumulation of Na+ in the skin of Chy and WT controls after HSD. 
DOCA induced Na+ accumulation in the skin and increased blood pressure in 
Chy and VEGFR3-Ig mice. However, no differences were found when compared 
to WT controls. VEGF-C and WT mice did not accumulate Na+ after DOCA. We 
found no lymphangiogenesis in skin after DOCA or HSD compared to NSD and 
LSD controls. In WT (C3H) Na+ accumulation led to increased migration of 
Langerhans cells from the skin. In genetically engineered and WT mice from all 
the three models, DOCA caused an increased Na+ and a reduced K+ 
concentration in skeletal muscle, compared to mice fed NSD and HSD. The total 
concentration of sodium and potassium in muscle was similar in all groups, 





The aim of this work was to study the role of the extracellular microenvironment 
and lymphatic vasculature in skin in electrolyte and blood pressure homeostasis. 
I will in this section first discuss some of the main methods and techniques used 
during the thesis and thereafter our main findings more in general.  
5.1 Methodological considerations 
5.1.1. Animal models of hypertension 
Animal models have been essential for all the studies presented in this thesis. As 
described earlier, the pathophysiology of hypertension in humans is 
multifactorial and complex (4, 14), and no animal model alone can recapitulate 
all the features of the disease process. There are many advantages of using 
animal models; e.g. they are relatively cost effective, give a standardized study 
population, have fast recovery time after surgery, and provide research 
opportunities to study the effects of genetic modifications, that will not be 
possible in human studies. However, there are also many differences that are 
important to keep in mind when comparing hypertension in rodents and humans, 
e.g. that the hemodynamics, like heart rate, of rodents are fundamentally 
different compared to humans. The normal resting heart rate in a mouse is 500-
700 beats per minute, which is approximately 10 times faster than in humans, 
resulting in a limited increase in cardiac output in mice by maximally 2-fold in 
comparison to a 10-fold increase in humans during stress (159). The fact that 
rodents walk on four feet might also influence the hemodynamic profile 
compared to humans that walk standing on two feet. The timeline for developing 
hypertension in the rodent models is very short compared to humans. It may take 
decades for a human to develop hypertension, as compared to animal models 
where the timeline is days to weeks. These aspects are important to be aware of 




5.1.2. Inducing hypertension 
Considering all the different factors that affect blood pressure, there is no ideal 
animal model that is the gold standard in hypertension research. Moreover, the 
reproducibility of hypertension models in animals has been a topic of discussion 
(160, 161). There are mainly three broad categories that animal models of 
hypertension can be divided into; spontaneous, surgically induced and 
pharmacologically or diet induced hypertension. Spontaneous hypertension 
models use animals that have a phenotype of developing hypertension 
spontaneously. These are primarily rat strains; most commonly the Dahl salt 
sensitive rats (DS) and Spontaneously Hypertensive rats (SHR). Surgical models 
involve the manipulation of renal blood flow, and this can be done by either 
constriction of one or both of the renal arteries, or by constriction of one renal 
artery with removal of the contralateral kidney. Our aim was to study the effect 
of salt on systemic blood pressure and the extracellular   microenvironment in 
the skin, and we used a HSD model alone or in combination with a 
mineralcorticosteroid hormone that caused retention of sodium, the DOCA 
model.  
The advantages of a HSD are that it is easy to administer and there is no use of 
invasive techniques. The increase in blood pressure caused by HSD alone is not 
always pronounced. There is also reported strain variation, some strains being 
more salt sensitive than others (162). The amount of salt consumed by rats and 
mice in this model is also quite high and the physiological relevance to eating 
chow containing, respectively 8% and 4% salt, and drink 1% saline might be 
questioned.  
The DOCA model results in a more pronounced rise in blood pressure. DOCA 
affects renal sodium handling, leading to reabsorption of sodium in the kidney 
(163). This model is often combined with unilateral nephrectomy to increase the 
hypertension, but studies have shown that animals also develop hypertension 
without unilateral nephrectomy (164). We chose the latter model in order to 
reduce the amount of invasive procedures that the animals were exposed to. In 
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our experiments all animal groups exposed to DOCA got a pronounced increase 
in blood pressure. The DOCA-salt model creates an imbalance in the renin-
angiotensin system and low-renin hypertension. Renin is also observed to be low 
in salt-sensitive persons, and it is advocated that the low renin phenomenon 
observed in the DOCA-salt model makes the model well suited to study salt-
sensitive hypertension (165, 166). The disadvantage with the DOCA model is 
that surgery is needed to implant the slow release tablet. At the beginning of the 
project we observed that the tablets dissolved and irritated the surgical wound, 
resulting in premature termination of the experiments. Inserting the tablet 
through a subcutaneous tunnel with a plastic catheter solved this problem, and 
this procedure was applied throughout the project.  
For the experiments involving rats given HSD or DOCA, we used LSD as a 
control group. The normal dietary salt requirement for rats has been a matter of 
discussion. It has been argued that normal commercial chow might contain 
sodium in excess of actual dietary needs and this might affect cardiovascular 
physiology (167). One the other hand, animals that receive LSD will have low 
levels of salt available in the chow. In earlier studies we have seen minimal 
differences between HSD and DOCA group sodium content, whereas LSD had 
significantly lower sodium content in skin (151). It is possible that these 
differences are not due to salt accumulation in the salt exposed groups but due 
to loss of salt from the skin in LSD groups. LSD is the most used control group 
in studies involving hypertension, although, from a physiological point of view 
it might be preferable to use NSD rather than LSD as a control group. We 
therefore used NSD as control group in some of the mouse experiments. 
5.1.3. Measuring blood pressure in rodents 
Four major techniques are used for measuring arterial blood pressure in rodents; 
the tail-cuff system, implanted fluid filled catheters, implanted telemetry systems 
and Millar tip pressure catheters (168). The first of these is a non-invasive 
method, whereas the three remaining are invasive. The implanted fluid catheters 
and Millar pressure catheters are not well suited for continuous blood pressure 
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recording over time and were therefore not ideal for use in our study, as we 
wanted to compare blood pressure before and after a diet that lasted for 2-3 
weeks. The tail cuff and the implanted telemetric systems are the best suited 
methods to assess steady state blood pressure over time. These were the preferred 
methods in our studies and will be discussed further.  
The tail-cuff system measures blood pressure by monitoring the volume of the 
tail as a measure of blood flow. The system consists of two rings, one for 
restriction and controlled re-initiation of blood flow in the tail (occlusion-cuff) 
and one for volume pressure recording (VPR-cuff). As the occlusion-cuff 
gradually releases pressure, blood flow into the tail will be restored and the 
volume of the tail will increase. When the blood flow in and out of the tail is 
equal there will be no changes in the volume of the tail. The timeline for these 
changes in the volume of the tail are recorded by the VPR-cuff. Systolic and 
diastolic pressures are determined by comparing the pressure in the occlusion-
cuff with the time for changes in volume of the tail.  The advantages of the tail 
cuff-system are that it is a non-invasive method that can be used in conscious 
animals for regular monitoring over time, it is cheap compared to other methods 
and simple to use. One disadvantage is that the animals must be restrained and 
will almost always experience some degree of stress during the inflation of the 
two balloons on the tail while blood pressure is measured. The blood flow in the 
tail is very sensitive to temperature changes and it is important that the animals 
are warm enough before starting the recording.   
The implanted telemetry system is considered the gold standard for measuring 
blood pressure in intact and conscious mice. In this method a catheter attached 
to small a transmitter is inserted into the carotid artery so that the tip of the 
catheter lies inside the aortic arch, while the transmitter is placed subcutaneously 
on the left side of the abdomen of the mice. The catheter tip, that is pre-filled 
with gel, senses pressure waves that the transmitter converts into radio signals, 
which are transmitted wirelessly to a receiver outside the cage. The radio signal 
recorded by the receiver is translated into blood pressure by a computer. The 
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major advantage with the implanted telemetry system is the possibility to 
measure blood pressure over longer time in conscious animals moving freely in 
their natural living environment. The major disadvantage is the high cost of the 
system related to purchase as well as maintenance of the transmitters. Moreover, 
the operation itself and the post-operative recovery period make it a more time 
consuming method than e.g. the tail-cuff system. Additionally, the method 
requires good surgical skills that take time to learn. The insertion of the catheter 
and transmitter is a rather traumatic procedure for the mice, with a high mortality 
rate. Experienced users of the telemetry system have reported a success rate of 
90% with carotid artery placement (169).  
Studies comparing the flow-based tail-cuff system and implanted telemetry 
system have shown conflicting results. Whereas some find good, others find a 
poor correlation (170, 171).  It seems that the tail-cuff system might be sufficient 
to measure blood pressure in rats, but given the variability found in mice, the 
American Heart Association recommend radiotelemetry for blood pressure 
measurements in mice in their latest statement regarding animal models of 
hypertension (161, 168, 170). Our experience was the same when measuring 
blood pressure in rats and mice with tail-cuff. Rats were calmer and easier to 
handle than mice. Mice appeared much more stressed with increased tail 
movement, as an indicator of stress (172), which was a constant source of error 
during inflation and deflation of the cuffs. Correct temperature of the tail was 
much harder to achieve in mice, which is crucial for blood flow in the tail. Hence, 
we concluded that telemetric recording was the preferred method for blood 
pressure measurements in mice.  
5.1.4. Immunohistochemistry 
Immunohistochemistry was chosen to quantify lymphatic and blood vessels, 
immune cells and chemokines. The advantage of immunohistochemistry is the 
low cost and the large numbers of easily accessible antibodies to detect specific 
proteins on cells and structures in the tissues. The possibility of using different 
chromogenic substrates or fluorescent markers makes it possible to stain for two 
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or more markers at the same time. If the same cell or structure expresses two 
different proteins, double staining with antigens for both proteins will make their 
identification and localization easier. Immunohistochemistry is a 
semiquantitative method, meaning that it is not quite precise. Mistakes in all 
parts of the assay performance may lead to variability and errors, e.g. handling 
and fixation of the tissue, sectioning, antigen retrieval, staining and 
quantification method (173). 
Whole mount staining of the ear was used for quantification of lymphatic vessels 
in the dermis of mice. This staining technique provides a better total picture of 
the lymphatic vasculature than a series of thin sections through the ear. During 
the preparation of the ears for whole mount staining it is easy to disrupt the 
lymphatic vasculature, resulting in areas with poor staining that seem to lack 
lymphatic vasculature. This might be a source of error when analysing the ears, 
and to avoid this we selected areas where the lymphatic vasculature appeared 
intact with regular staining. Rat ears have a much thicker layer of connective 
tissue and when we performed whole mount staining on these, the lymphatic 
vasculature was much more disrupted and the staining became irregular after 
preparation. We therefore chose serial sections for quantification of lymphatic 
vessels in the skin of rats.  
5.1.5. Flow cytometry  
Flow cytometry is a laser/impedance-based technology with the ability to 
analyse thousands of particles rapidly. We used this method to study immune 
cell migration from skin to the draining lymph nodes.  The principle behind the 
technology is the passage of cells in a single file in front of a laser. The cells are 
prepared in a suspension where fluorescent labelled antibodies, specific for the 
cells of interest to be examined, are added. The fluorochromes are excited by a 
laser and detection of the fluorescence is used to determine the cell type. By 
using fluorochromes with different absorption and emission spectra and lasers 
with different wavelengths, multiple antigens can be analysed at the same time 
to determine type and quantity of cells present in the suspension (174). Flow 
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cytometry is thus an ideal tool for the identification of small cell populations in 
more complex cell suspensions from e.g. a lymph node. There are limitations of 
this technique that are important to be aware of. Standardization of methods 
across laboratories is poor, and data interpretation is to some extent subjective. 
The use of multicolour flow cytometry increases the risk of physical overlap 
between the different fluorochromes emission spectra, termed spillover, 
meaning that a signal from one antibody can optically interfere with signals from 
others. To avoid spillover it is important to select fluorochromes where this 
effect is minimal. A process called compensation can correct for spillover. The 
goal of compensation is to neutralize the signals from an antibody from all other 
channels than its own. This is achieved by single-color controls and software that 
calculates spillover values, which are placed in a compensation matrix with the 
use of matrix algebra. For better identification between positive and negative 
populations, Fluorescence Minus One (FMO) controls can be used. These 
controls are cell samples from the experiment that are stained with all 
fluorochromes used except one. FMO controls help to better distinguish true 
positive staining of a cell population from spillover and background fluorescence 
and are thereby an important tool for a more precise analysis of flow cytometry 
data.  
The migrated dendritic cell population in the lymph nodes after FITC painting 
that are detected with flow cytometry makes up a very small percentage of the 
total cell population, in most studies less than 1% (109). As negative control we 
used a lymph node draining an area from the skin where no FITC were applied. 
This negative control is equivalent to a FMO sample, and when compared to the 
FITC positive lymph node we clearly found a distinct FITC+ MHC II++ 
population of migrating cells. As FITC positive cell make up a small percentage 
of the total number of cells in a lymph node, a small increase in migrating cells 
might be difficult to detect when analysing the data.  
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5.1.6. Lymph flow 
As previously discussed, studies have shown that salt loading might lead to 
accumulation of salt in the skin, resulting in activation of immune cells and 
lymphangiogenesis (11, 13). To address the question if this might lead to 
enhanced lymph flow we indirectly measured lymph flow as clearance of 
injected Alexa-680-labelled albumin from the skin with an optical imager (158). 
Albumin has a molecular weight of approximately 67 kDa, which is within the 
optimal range for tissue washout through the lymph only (47). The volume of 
injected albumin is low to reduce the likelihood of an increase in Pif, which might 
contribute to an increase in the filling pressure of the lymphatic vasculature and 
thereby falsely increase lymph flow. The labelled albumin is stable and the 
injected solution is without any free dye to avoid unspecific binding to other 
extracellular proteins in the interstitium and clearance of free dye. For other 
methods used to measure lymph flow, such as clearance of Evans blue dye, this 
might be a problem as the dye binds to extracellular matrix proteins and free dye 
may be absorbed by the venous system (175). Because lymph flow is dependent 
on movement of the extremities, the animals were awake and freely moving 
during the experiment, expect for the brief period during scanning. Pif was 
measured with micropipettes which is a practically atraumatic method and does 
not influence the fluid balance in the tissue (176). 
A limitation of optical scanning is that it can only be applied in superficial 
tissues, like the skin. To assess the lymph flow in muscle we needed a method 
that was able to detect tracer molecules in deeper structures. We developed a 
PET/CT method where we injected the PET-emitter 124I into a thigh muscle and 
determined clearance of the tracer with PET/CT at different time intervals. This 
method presents a new alternative for the determination of lymph flow, but is 
expensive and requires staff trained in the use of PET/CT and radioactive tracers.  
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5.2 General discussion 
5.2.1 Lymphangiogenesis and function 
Formation of new lymph vessels due to VEGF-C secretion from immune cells is 
suggested to be important for electrolyte homeostasis, and thereby blood 
pressure regulation (11, 15). The knowledge on the functional consequences of 
lymphangiogenesis is scarce. We therefore aimed to study the lymphatic 
function in a situation with a chronically expanded lymphatic network. We 
verified that the transgenic K14-VEGF-C mice have a hyperplastic lymphatic 
network and thereby should be a good animal model to study potential functional 
consequences of VEGF-C overexpression in skin (paper I). Results from 
previous studies of the lymphatic function in models of lymphangiogenesis are 
diverging, showing both increased, similar or reduced lymph flow during 
inflammation (69, 177-180). In our models, we found reduced lymph flow to the 
same extent in both VEGF-C and WT after inducing acute and chronic 
inflammation (paper I). The reduction in lymph flow occurred even though 
tissue water and Pif were increased, which in a situation without inflammation 
would be a driving force for lymph formation (57). Despite increased Pif due to 
enhanced capillary fluid filtration in inflammation, inflammatory mediators like 
NO have been shown to reduce the contractility strength and frequency in 
collecting lymph vessels, resulting in impaired lymph flow (181). The finding of 
similar reduction in lymph flow in VEGF-C and control mice during 
inflammation is contrasting to other studies in similar models of 
lymphangiogenesis (174). Our method of measuring clearance of labelled 
albumin with optical imaging should be better suited to determine lymph flow 
compared to clearance of Evans blue, as discussed previously, and could be an 
important factor to explain differences between our results and previous 
findings. To study lymph flow capacity during local overhydration we injected 
fluid intradermally. This injection led to local increase in tissue fluid and Pif in 
both genotypes, however, to a higher increase in lymph flow in the transgenic 
mice compared to WT mice. We concluded that resistance to filling of the 
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lymphatics was reduced in the VEGF-C overexpressing mice, suggesting that a 
hyperplastic lymphatic network is capable of an enhanced transport of fluid 
driven by increased Pif  (paper I). 
Migrating immune cells is an important component of lymph, and should be 
taken into account when evaluating lymphatic function. We addressed this 
question by using the FITC-painting to induce local inflammation on the ear and 
count the FITC positive cells in the draining lymph node after 18 hours. 
Although transgenic mice express nearly twice as much of the immune cell 
attractant CCL21 in the skin, FITC painting stimulated dendritic cell migration 
to the same extent in both WT and transgenic mice (paper I). This could be 
explained by suppression of CCL21 receptors on migrating dendritic cells in 
VEGF-C overexpressing mice (182) and an increased gradient of CCL21 is 
therefore not sufficient to induce increased migration of dendritic cells to lymph 
nodes.    
Our results indicate that the assumption of a connection between an increased 
lymphatic network and increased function is necessarily not correct. It should be 
noticed, however, that our conclusion is based on the finding in a model where 
chronical overexpression of VEGF-C induces lymphangiogenesis, and that the 
situation might be different when the lymphangiogenesis is induced by Na+ 
accumulation. 
In paper II, we addressed how accumulation of Na+ in the skin affects lymphatic 
vasculature and function. Rats in the HSD and DOCA group increased the 
number of lymph capillaries in the skin. A tendency of increased lymph flow 
compared to the control group was found in HSD and DOCA. However, when 
we included overnight measurement period there was a significantly increased 
lymph flow in high salt conditions. Even if the effect appears modest, it is 
important to keep in mind that a small increase in lymph flow will, over a longer 
period, increase the transport of fluid and electrolytes correspondingly and 
thereby significantly.  
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It has been reported an increase in the number of lymph capillaries in skin 
increase in rats and mice after salt loading, with one study reporting a twofold 
increase in lymphatic vasculature in ear of mice fed HSD (11). In mice we were 
not able to verify increased lymphangiogenesis after Na+ accumulation in the 
skin (paper III). A reason for the substantial discrepancy between our and 
previous data might be the selection of area for quantification. Lymphatic 
vasculature is easily disrupted when preparing ears for whole-mount staining, 
appearing as areas with irregular or no lymphatic vasculature. We therefore 
selected 3-5 areas that appeared intact with a continuous lymphatic network for 
quantification. In rats we were able to verify lymphangiogenesis after salt 
loading by quantification of lymphatic vessels in serial sections (paper II). The 
discrepancy between mice and rats could be explained by the different methods 
used. Whole-mount might not be accurate enough to detect small changes, which 
is better demonstrated by the serial sections. However, our findings indicate that 
salt accumulation does not stimulate lymphangiogenesis to the same extent as 
previously reported.  
5.2.2 Blood pressure and lymphatics in the skin 
Immune cells have been proposed to play a central role in the new hypothesis on 
salt-sensitive hypertension by producing VEGF-C during hypertonic conditions 
(11, 13). Depletion of macrophages in the skin by clodronate resulted in 
significant reduction in lymph flow, supporting the assumption that this cell type 
might be involved in lymphangiogenesis and lymph flow response observed 
during salt loading (paper II). Blocking lymphangiogenesis has been reported 
to result in more salt-sensitive animals with higher blood pressure after salt 
loading (13). Oppositely, we wanted to explore if existing lymphatic vasculature 
in the skin might affect blood pressure homeostasis during salt loading. Baseline 
blood pressure was the same in genetically engineered mice with either 
hyperplastic or reduced lymphatic skin vasculature as in WT controls (paper 
III). DOCA induced increased blood pressure to the same extent in mice with 
reduced lymphatic network and WT control mice, while HSD was insufficient 
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to induce blood pressure rise in any of the mouse models. In contrast, previous 
studies have reported higher blood pressure after HSD in mice lacking lymphatic 
vasculature in skin compared to mice with normal lymphatics, using the same 
mouse model (13). In the latter study, mice were awake in a restrainer while 
blood pressure was measured with an arterial line in the carotid artery one hour 
after insertion. It is likely that this method induced stress and thereby that the 
procedure itself results in an increase in blood pressure. In a later study, it was 
acknowledged that this method was not suitable for measurement of steady state 
blood pressure, but rather provides a method to measure stress-induced 
hypertension (183).  
Dendritic cells have been reported to be involved in development salt-sensitive 
hypertension (134, 184). Increased dendritic cell migration from skin to the 
draining lymph in mice after DOCA might support the hypothesis that salt 
loading induces an immune response in the skin (paper III). Apparently, a 
hyperplastic lymphatic network does not itself lead to increased cell migration 
(paper I), indicating that the increased migration is due to other factors. If salt 
creates an inflammation in the skin with increased number of activated immune 
cells that secrete inflammatory mediators like VEGF-C, the observed increase in 
lymphatic vessels (paper II) might be a result of such inflammation. The 
reduced lymph flow in the skin observed after depletion of macrophages indicate 
that immune cells might be involved in lymphatic function (paper II). However, 
our results indicate that lymphangiogenesis per se does not affect blood pressure 
homeostasis (paper III). An increase of macrophages and no difference in the 
density of lymphatic vessels has also been found in the skin of patients with 
hypertension when compared to a normotensive control group (185).  
Overall, our results indicate that lymphatic vasculature in the skin does not affect 
blood pressure homeostasis in mice after salt loading. This statement is 
supported by a recent study where the conclusion was that salt-sensitive 
hypertension seen after the use of sunitinib, a vascular endothelial growth factor 
inhibitor, is not due to impairment of skin lymphangiogenesis (186).  
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5.2.3 Salt accumulation in tissue  
We found that rats accumulate Na+ in the skin after HSD and DOCA (paper II). 
In contrast there was no accumulation of Na+ in skin of mice after HSD, only 
after DOCA. There was no difference in salt content in the skin between 
genetically engineered and control mice (paper III). In a preliminary study, 
however, we found that the sodium content was reduced in the skin of FVB WT 
and VEGF-C mice after 5 weeks LSD, indicating a wash out of Na+ from the 
skin. Still, Na+ was reduced to the same extent in both groups. Overall, these 
findings indicate that skin might serve as reservoir for Na+. The differences in 
Na+ accumulation between rats and mice after HSD might indicate that there are 
differences between species in the capability to store Na+ in the skin.  
DOCA induced a shift in Na+ and K+ balance in skeletal muscle, with increased 
Na+ concentration and reduced concentration of K+ (paper III). The shift of Na+ 
and K+ in muscle was the same in WT and genetically engineered mice and in 
agreement with other studies using DOCA (187, 188). Relative to skin, muscle 
has a high cell mass relative to interstitial space, making it a large depot for 
transcellular exchange of Na+ for K+. NaMRI studies in humans have indicated 
that Na+ appears to accumulate in muscle (153) and the increased lymph flow 
observed in rat muscle might be a result of such accumulation (paper II). In 
another preliminary study we also found redistribution of Na+ and K+ in the 
myocardium after DOCA, although not so prominent as in skeletal muscle. The 
membrane potential is crucial for heart function, and the regulation of potassium 
and sodium through the sodium-potassium pump is much more effectively 
controlled in heart compared to skeletal muscle (189).  
 
DOCA and aldosterone both bind to mineralocorticoid receptors (MRs) with 
similar high affinity (190). MRs are best known as regulators of sodium and 
potassium transport in epithelial cells in the kidney and colon, but they are also 
expressed widely at low levels in heart, skeletal and smooth muscle (191, 192). 
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The shift of Na+ and K+ found in skeletal and heart muscle might be due to 
activation of MRs (paper III). In agreement with previous studies (187) we 
found no shift in the Na+ and K+ balance in muscle on HSD alone. However, 
further studies to look for a potential effect of HSD on the Na+ and K+ 
concentration in muscle would be of interest, especially in rats where an 






The overall aim of this thesis was to study the role of the extracellular 
microenvironment and lymphatics in electrolyte and blood pressure regulation. 
Based on our studies in different animal models, we may conclude the following: 
 
 Augmented lymphatic vasculature in the skin reduces resistance to lymph 
formation and facilitates enhanced clearance of fluid in situations with 
increased fluid filtration. In inflammation, lymph flow is however 
reduced. A hyperplastic lymphatic network expresses more 
chemoattractants, but this does not increase immune cell migration from 
the skin to the draining lymph node.  
 
 Rats accumulate Na+ in the skin, which induces lymphangiogenesis and 
is associated with increased lymph flow in the skin. Salt loading in rats 
moreover affect lymph flow in muscle, suggesting that also muscle may 
contribute in electrolyte and blood pressure homeostasis.  
 
 Lymphatic vasculature in the skin does not affect skin accumulation of 
Na+ or blood pressure homeostasis in mice. Accumulation of Na+ does 
not stimulate lymphangiogenesis in mice. However, Na+ accumulation 
might stimulate a general increase in immune cell activity in skin. DOCA 




7. Future perspectives 
 
Although the evidence for a role of skin lymphatics in salt-sensitive hypertension 
is scarce, it seems that this idea is becoming more and more established as a fact. 
Our data, as well as others (186), do not support the strong connection between 
lymphangiogenesis and electrolyte and blood pressure homeostasis as previously 
reported.  It is important to continue the work on skin accumulation of Na+ to 
achieve a better understanding of the potential functional consequences, both 
regarding physiological changes and immune responses.  
Our finding of sodium accumulation in muscle after DOCA has not been well 
described before.  In subjects with resistant hypertension (RHTN), which is 
defined as the use of three or more antihypertensive drugs to control blood 
pressure, studies have shown that MR inhibitors might be useful to lower blood 
pressure (193). RHTN and MR-associated hypertension are linked to obesity, 
diabetes mellitus, polycystic ovary syndrome and chronic kidney disease (194). 
Excess aldosterone is often present in obesity, and patients with obesity are more 
likely to be salt-sensitive (195). The observation of increased sodium in muscle 
in hypertensive patients with 23Na-MRI and a reduction of blood pressure and 
sodium content in muscle after treatment with the MR antagonist spironolactone 
may indicate that sodium storage and MRs in the muscle may play a role in salt-
sensitive hypertension (153). Our findings of increased lymph flow in muscle 
after salt loading and changes in the sodium and potassium balance in skeletal 
and heart muscle after DOCA should be further addressed and might give a better 
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Objective: Lymphatic vessels play an important role in body fluid as well as 
immune system homeostasis. Whereas the role of malfunctioning or missing 
lymphatics has been studied extensively, less is known on the functional 
consequences of a chronically expanded lymphatic network or 
lymphangiogenesis.  
Approach and Results: To this end, we used K14-VEGF-C transgenic mice 
overexpressing the vascular endothelial growth factor C in skin, and investigated 
the responses to inflammatory and fluid volume challenges. We also recorded 
interstitial fluid pressure, a major determinant of lymph flow. Transgenic mice 
had a strongly enhanced lymph vessel area in skin. Acute inflammation induced 
by lipopolysaccharide and chronic inflammation by delayed-type hypersensitivity 
both resulted in increased interstitial fluid pressure and reduced lymph flow, both 
to the same extent in wild type and transgenic mice. Hyperplastic lymphatic 
vessels, however, demonstrated enhanced transport capacity after local fluid 
overload not induced by inflammation. In this situation, interstitial fluid pressure 
was increased to a similar extent in the two strains, thus suggesting that the 
enhanced lymph vessel area facilitated initial lymph formation. The increased 
lymph vessel area resulted in an enhanced production of the chemoattractant 
CCL21 that, however, did not result in augmented dendritic cell migration after 
induction of local skin inflammation by fluorescein isothiocyanate.  
Conclusions: An expanded lymphatic network is capable of enhanced 
chemoattractant production, and lymphangiogenesis will facilitate initial lymph 




BSA; bovine serum albumin 
FITC; fluorescein isothiocyanate 
HSA; human serum albumin 
K14; keratin-14 
LPS; lipopolysaccharide 
Lyve-1; lymph vessel endothelial hyaluronan receptor-1 
Pif; interstitial fluid pressure 
TTW; total tissue water 




 Lymphatic vessels play an important role in body fluid as well as immune 
system homeostasis. To maintain fluid homeostasis, the filtration of fluid and 
plasma proteins must be balanced by the formation of lymph that is transported 
into initial lymphatics and eventually returned to the general circulation. Lymph 
vessels are also the major transporters of soluble antigens and antigen-presenting 
cells from peripheral tissues to lymph nodes where they mount an immune 
response(196). The discovery of lymph vessel growth factors and molecular 
markers two decades ago enabled us to ask new and targeted questions and has 
led to a dramatic increase in available knowledge in this field. 
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 Malfunctioning or missing lymphatics may result in tissue fluid 
accumulation and lymphedema that has been studied extensively in experimental 
models as well as clinically (for review see(196, 197)). Less is known, however, 
on the functional consequences of a chronically expanded lymphatic network. It is 
well established that many inflammatory conditions result in an expansion of 
initial lymphatics and lymphatic remodeling(198, 199), and that the 
lymphangiogenic factor Vascular Endothelial Growth Factor (VEGF)-C plays a 
central role in these processes. In skin, it has been shown that stimulation of 
lymphangiogenesis by VEGFR-3 or its ligand VEGF-C reduces acute and chronic 
inflammation, most likely mediated by a stimulation of lymph drainage from the 
inflamed tissue(178, 200, 201). In contrast, in models known to stimulate 
lymphangiogenesis, other groups have shown either no change in clearance(179), 
or a reduced lymphatic pumping activity indicating a reduced clearance in acute 
inflammation(180, 202).  
 Previous data on the function of an expanded lymphatic network are 
therefore conflicting. In this context, it is pertinent to remember that both 
components of lymph, fluid and cells, should be taken into account when 
evaluating lymphatic function. Moreover, interstitial fluid pressure (Pif) is a major 
determinant of lymph flow(47), transcapillary fluid balance and interstitial fluid 
volume, and this parameter has not been evaluated in a situation with an 
expanded lymphatic network.  
In the present study, we therefore aimed to resolve questions related to the 
function of an expanded lymphatic network discussed above, or to state it 
differently, what lymphangiogenesis achieves(203). To this end we applied a 
transgenic mouse model stably overexpressing human VEGF-C in the skin under 
the control of the keratin-14 (K14) promoter(75). This model could be used to ask 
questions of lymphatic function related to inherent or induced lymphangiogenesis 
by applying a recently developed optical imaging method to record lymph flow. 
We found that VEGF-C overexpression did not affect tissue hydration and Pif in 
control situation. Moreover, these parameters were not differently influenced in 
the two strains in acute and chronic inflammation. Hyperplastic lymphatic vessels, 
however, had increased transport capacity in a situation involving fluid overload 
not induced by inflammation. These findings imply that the hyperplastic vessels 
facilitate initial lymph formation and thus increase transport rate provided the 
absence of inflammatory mediators. Nevertheless, the hyperplastic vessels were 
not capable of inducing increased immune cell migration in spite of an enhanced 
production of immune cell chemoattractants.  
 
Materials and Methods 
Materials and Methods are available in the online-only Data Supplement. 
 
Results 
Lymphatic vessel area in the skin is substantially enlarged in K14-VEGF-C mice 
Our major aim was to resolve questions related to the function of an 
expanded lymphatic network, and thereby what is achieved by 
lymphangiogenesis(203). To this end we chose an established transgenic model 
overexpressing VEGF-C in skin(75). To confirm that K14-VEGF-C overexpression 
led to increased lymphangiogenesis we performed whole mount staining on WT 
and K14-VEGF-C ears, co-staining with the lymphatic specific marker LYVE-1 and 
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the blood vessel marker CD31. In line with previous studies on K14-VEGF-C mice, 
we found a much denser ear lymphatic network in K14-VEGF-C than in WT mice 
(Fig 1A) with a ≈100% increase in LYVE-1+ area (Fig. 1B). On the other hand, the 
blood vessel network as stained with CD31 in K14-VEGF-C mice appeared normal 
(Fig. 1A), and the blood vessel area was not different in the two strains (Fig 1B). 
We also assessed the lymph vessels in other regions to study whether the 
phenotype applied to all skin areas.  Serial sections of paw and back skin 
confirmed a significant increase in LYVE-1+ lymphatic vessel area in K14-VEGF-C 
mice (Fig. 1 C), and thereby that this model was suitable for functional studies of 
lymphangiogenesis. 
 
Lymphatic drainage and fluid balance parameters are similar to WT in K14-
VEGF-C mice in control situation and during inflammation 
To assess whether the expanded lymphatic network influenced lymphatic 
drainage from the skin, we injected 0.5 µl Alexa680-labelled bovine serum 
albumin into the dermis of the hind paw and followed the washout of tracer by 
optical imaging over the course of 6 hours. The removal of albumin is restricted 
exclusively to lymphatics due to its size, and will thus reflect lymph flow from the 
injected area. To facilitate lymph flow, the mice were freely moving in their cage 
in between the hourly imaging sessions. Despite having more lymphatic vessels 
than WT mice, washout of tracer and thereby lymph flow in K14-VEGF-C mice was 
similar to WT (Fig. 2A). The equal lymph flow suggested a similar lymph 
production and protein extravasation. We therefore assessed the extravasation of 
radioactively labelled albumin, and found the protein extravasation to be not 
different in the two strains in the unperturbed control situation (Fig. 2B). The 
similar lymph flow and protein extravasation suggest that the lymph production, 
i.e. transcapillary fluid filtration, is equal in the two strains.  
The fluid volume parameters and potential drivers of lymph flow, total 
tissue water (TTW) and interstitial fluid pressure (Pif), were also found to be not 
different from WT in K14-VEGF-C mice hind paw (Fig. 3A,C) and ear (Fig. 3B,D) in 
control situation. These findings were also reflected in back skin (data not shown). 
Moreover, systolic as well as mean arterial blood pressures were similar, 
averaging 113 ± 5 mm Hg (systolic) and 92 ± 3 mmHg (mean) in WT (n=11) with 
corresponding pressures of 114 ± 4 mmHg and 92 ± 4 mmHg in K14-VEGF-C mice 
(n=10). 
We hypothesized that a potential difference in transport capacity of the 
two strains would manifest in skin inflammation known to induce an increase in 
capillary filtration. To induce inflammation, we used two models, one acute based 
on injection of lipopolysaccharide (LPS) and one chronic based on topical 
application of oxazolone that will induce delayed-type hypersensitivity. Seven 
days after the initial sensitization with 2% oxazolone, and 2 days after challenge 
(1% oxazolone) we measured lymph flow, Pif and TTW. The delayed-type 
hypersensitivity response resulted in significantly increased TTW in paw skin 
(Fig. 3A) and ear (Fig. 3B) as well as Pif in corresponding sites (Fig. 3C,D) reflecting 
accumulation of fluid, but to the same extent in both strains.  
The observed increase in Pif, again a consequence of increased fluid 
accumulation during inflammation, will represent an increased driving force for 
filling of initial lymphatics that might promote lymph drainage(47). We observed, 
however, that lymph transport was significantly halted in oxazolone-induced 
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inflammation, resulting in an equally reduced washout rate of ≈15% in both 
strains when compared with the control situation (Fig. 2C).  
We also induced an acute inflammation by local injection of LPS. LPS 
actually resulted in an increase in TTW and Pif that was even more pronounced 
than the corresponding responses observed after oxazolone treatment in paw 
skin (Fig 3A,C) as well as ear (Fig. 3B,D). Surprisingly, more fluid accumulated in 
the ear in K14-VEGF-C than in WT (Fig. 3B), an effect that was not seen in the paw 
(Fig. 3A). In spite of an even stronger stimulus for lymph vessel filling, the 
reduction in lymphatic tracer washout was even more reduced than in oxazolone-
induced inflammation, amounting to 43% in K14-VEGF-C and 38% in WT when 
compared with respective controls (Fig 2C). Moreover, this impeded lymph flow 
effect was long-lasting, as shown by the observation of close to twice the amount 
of tracer retained in skin 24 h after LPS injection in both strains (Fig 2D).  
 
Interstitial fluid volume overload increases lymph flow to a greater extent in 
K14-VEGF-C mice 
As described above we observed no effect of an increased lymph vessel 
area after induction of lymphangiogenesis after acute as well as chronic 
inflammation. Inflammation may, however, result in the release of numerous 
mediators, notably NO, that can interfere with lymphatic endothelial function and 
result in lymphatic contractile dysfunction(45), and thus counteract the stimulus 
effect of increased capillary filtration and interstitial fluid volume on lymphatic 
flow. To separate these effects, we investigated whether there were functional 
consequences of an expanded lymphatic network in a situation where solely the 
interstitial volume was increased by assessing lymph flow in the two strains after 
local overhydration. To this end, we injected 30 µl isotonic saline into the dermis 
of the hind paw with an insulin syringe after an initial control washout period 
lasting for 120 min (Fig 4A). In response to the fluid volume overload at 180 min, 
the K14-VEGF-C mice experienced a faster washout of tracer for the following 
period up to 300 min compared to WT (Fig. 4A), quantified as an increase (more 
negative) in average rate constant k of 25% in K14-VEGF-C compared with WT 
mice (Fig 4B).  
To investigate the local driving pressure for lymph formation we also 
assessed Pif in the overhydrated skin area. We found that the local Pif increased 
dramatically, from average values of -1 mm Hg in control situation before injection 
to 7-8 mm Hg immediately after injection (Fig. 4C). Although Pif in the K14-VEGF-
C in the first period after injection (denoted “0” in Fig. 4C) tended to be lower than 
in WT, this difference was not significant (P=0.12). The pressure subsided 
gradually, but was still higher than control pressure 120 min after saline injection 
in both strains. The observed increased lymph transport capacity in K14-VEGF-C 
in spite of a similar (or slightly lower) pressure gradient for lymph vessel filling 
suggests that the enhanced lymph vessel area in this strain facilitates initial lymph 
formation compared with WT. 
 
Reduced effect of local interstitial fluid overload on lymph flow in Chy mice 
To study the effect of lymphatic hypoplasia on local overhydration we 
injected 30 l isotonic saline into hindlimb skin of Chy mice missing initial 
lymphatic vessels in dermis resulting in lymphedema(155). In agreement with 
previous studies(158), Chy mice had visible hindlimb edema, lower washout rate, 
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and thus lymph formation and flow, than WT mice in control situation before local 
saline injection (Fig 5A). This occurred in spite of an increased Pif and thus driving 
pressure for lymph formation (Fig. 5C), suggesting the initial lymph formation was 
impeded even in control situation. Intradermal injection of 30 µl isotonic saline 
into the same hind paw resulted in an apparent immediate, but not significant, 
increase in washout in the Chy mice (Fig. 5A).  As described above, there was, 
however, an increase in washout in WT mice after this local volume stimulus, 
maintaining the difference in rate constants (k) between the strains compared 
with the control situation (Fig 5B). Apparently, the increased driving pressure for 
lymph formation, Pif, in control situation (Fig 5C) could not counteract the 
reduction in control lymph flow in Chy. Surprisingly, there was a more 
pronounced increase in Pif in WT than in Chy after local overhydration (Fig 5C), 
but this is likely a result of a faster local fluid volume and pressure dissipation in 
the Chy hindlimb, because of a strongly increased hydraulic conductivity in 
edema(204).  The observed reduced lymph transport capacity in Chy in spite of an 
increased pressure gradient for lymph vessel filling in control situation, and a 
similar gradient >60 min after local overhydration, suggests that the reduced 
lymph vessel area in Chy results in an increased impediment of initial lymph 
formation compared with WT. 
 
Synthesis of CCL21 and migration of immune cells from skin enhanced in K14-
VEGF-C mice 
Lymphatic vasculature has been shown to be highly dynamic, and 
lymphatic endothelial cells are producers of chemokines and adhesion molecules 
that play active roles in inflammatory and immune processes(198). We asked 
whether the enhanced area of LYVE-1+ lymphatics shown in K14-VEGF-C mice 
resulted in an increased content of the chemokine CCL21, known as one of the 
most central immune cell, notably dendritic cell, attractants in skin(116). By 
whole mount staining, we showed the presence of CCL21 in LYVE-1+ initial 
lymphatics in skin (Fig. 6A). Interestingly, when CCL21 expression was calculated 
as % area per field of view, the expression in the transgenic mice was almost twice 
that of WT mice (Fig. 6B), suggesting a higher content of this chemokine in the 
transgenic mice. The positive staining per lymph vessel area, however, did not 
differ in K14-VEGF-C and WT mice (Fig 6C). 
We then tested whether the increased content of CCL21 affected migration 
of immune cells from skin. First, we assessed the number of dendritic cells 
determined as CD207+/MHC+ cells in ear skin from epidermal sheets, and found 
no difference between the strains during control conditions (Fig. 7A,B).  We then 
induced local inflammation by painting with fluoroisothiocyanate (FITC), and 
recorded the cell uptake in draining lymph nodes by flow cytometry. There was 
no increased migration of FITC positive MHCII+CD11c+ cells neither at 12 h (data 
not shown) or at 18 h after painting (Fig. 7C), suggesting that even though there 
was an enhanced lymph vessel area producing the dendritic cell mobilizing 
chemokine CCL21 in K14-VEGF-C mice, this had no effect on dendritic cell 
migration to the draining lymph node.  
 
Discussion 
Whether the formation of new lymphatics, i.e. lymphangiogenesis, has 
functional consequences for lymphatic transport is a controversial issue that was 
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addressed in the present study. To this end, we used a transgenic mouse model 
expressing VEGF-C in keratinocytes, producing a hyperplastic lymphatic network 
in skin. Transgenic mice had normal water content, Pif, capillary permeability and 
lymph flow during control conditions suggesting a normal capillary barrier. 
Induction of acute as well as chronic inflammation reduced lymph flow to an equal 
extent in transgenic and WT mice. Interestingly, local infusion of fluid in skin 
stimulated fluid removal more forcefully in the transgenic mice. Such an expanded 
lymphatic network is capable of enhanced clearance of fluid, possibly because of 
an increased area that will offer less resistance to fluid uptake and thus facilitate 
initial lymph formation. In spite of an increased production of the DC mobilizing 
chemokine CCL21, however, immune cell migration from skin was unchanged. Our 
data suggest that an expanded lymphatic network is capable of enhanced 
clearance of fluid provided that there is an increased interstitial fluid driving 
pressure for filling of initial lymphatics, and that the downstream pumping 
capacity is not compromised by, e.g., an acute inflammation. 
 
Evaluation of methods  
 When attempting to understand diverging results derived from various 
studies on the functional role of lymphatics, a closer analysis of the methods used 
is pertinent since methodological aspects may explain at least some of this 
variation. Here we chose an extensively evaluated near infrared imaging method 
to assess lymph flow. This method is based on washout of Alexa-680-labelled 
albumin with a molecular weight of ≈67 kDa and thus within the optimal range for 
tissue clearance through lymph(158). Moreover, with this technique, the injection 
volume is low, that will reduce the possibility of an increase in local Pif that per se 
will contribute to an increased filling pressure of lymphatics and thereby 
artificially enhanced lymph flow. The imaging probe is also very stable and 
without any free dye. Thereby unspecific binding to proteins in the tissue as well 
as clearance of free dye to plasma is not a problem, as might be expected with e.g. 
Evans blue and Indocyanin green(205, 206). Although well suited for paw and 
back skin, we experienced problems with exact positioning and tissue photon 
absorption when imaging the ear, resulting in variable count recovery and non-
linear washout curves. Although the ear is a frequently used site for studies of skin 
fluid homeostasis, we therefore chose paw skin as our preferential area of study. 
We also chose the micropipette method for measurement of Pif that is practically 
atraumatic and does not add to or remove fluid from the tissue to minimize trauma 
and fluid volume artifacts.  
 
Comparison to previous studies 
The conspicuous change in lymphatic vessel area in the K14-VEGF-C mouse 
model had no obvious transcapillary fluid exchange phenotype in control 
situation; the protein extravasation, Pif, and tissue water content was not different 
from that in WT mice. Since these parameters were not different, it is to be 
expected that the lymph flow is not different, as actually observed. In contrast, 
Huggenberger et al(200) found an increased skin lymph flow in the K14-VEGF-C 
model based on clearance of Evans blue, a tracer that is not well suited for 
quantification of lymph flow as discussed above. Moreover, an increase was also 
found in a recent study based on tissue clearance of near infrared tracer(182).  
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In light of several previous observations of an increased clearance of tissue 
fluid in closely related models(178, 179, 200, 201), it was surprising that we 
actually found a similarly reduced lymph flow in K14-VEGF-C and WT mice in two 
different models of skin inflammation, i.e. that there was no lymph flow effect of 
enhanced lymphangiogenesis. This occurred in spite of an increased amount of 
tissue water and a higher Pif that should both act as a driving force for increased 
lymph formation and flow(47, 57). Still, a reduced lymph pumping has been 
shown in many types of inflammation as recently summarized by Scallan et al(45), 
notably in acute inflammation induced by LPS(207) as well as in delayed-type 
hypersensitivity induced by oxazolone(202), as used here. Release of NO will 
inhibit lymphatic tone and spontaneous contractions(45), and it is likely that 
iNOS, shown to be released by immune cells locally in inflamed tissue(202), 
contributed to the reduced lymph flow seen in both our inflammation models. 
There are several factors that may explain discrepancies between our and 
previous data. One of these is variation of iNOS-expression between mouse 
strains(45), and other factors are the methods used to assess lymph flow as 
discussed above. 
Because initial lymphatics also take up and transport immune cells to 
draining lymph nodes where they influence the immune response, we also 
assessed dendritic cells in skin and their ability to migrate to draining lymph 
nodes after stimulation with FITC. The DC numbers as well as their migration was 
unaffected by strain, in spite of a markedly increased level of the lymphoid homing 
cytokine CCL21 in the K14-VEGF-C mice. Apparently, the increased lymphatic 
vessel area is capable of augmenting the production and thereby the gradient of 
chemoattractants, but this is not sufficient to mobilize tissue resident immune 
cells to initial lymphatics. The reason might be downregulation of the CC 
chemokine receptor 7 (CCR-7) for which CCL21 serves as a ligand on DCs that may 
occur in VEGF-C overexpressing mice(182). It should be noted, though, that our 
findings are a result of VEGF-C overexpression only, and that the situation may be 
different in more complex models where the lymphangiogenesis is induced by 
inflammation(199) 
 
Mechanism for lymph formation  
To our knowledge, all previous studies on the K14-VEGF-C model have 
used interventions involving inflammation. As discussed above, inflammatory 
reactions will result in capillary hyperfiltration, fluid extravasation and thereby 
increased tissue fluid content. Accumulated fluid will result in an increased Pif, and 
together these parameters will stimulate filling of the initial lymphatics and fluid 
transport. In inflammation, this picture is complicated by the fact that several 
inflammatory mediators, notably NO, have an inhibitory effect on collecting vessel 
pumping, thereby counteracting the effect of increased volume and pressure. The 
tipping of the balance in one or the other direction may explain the diverging 
results discussed above. To avoid the influence of inflammation we injected fluid 
directly intradermally, and could thereby show that the expanded lymphatic 
network was actually capable of an enhanced lymphatic fluid transport that was 
driven by a local increase in volume and Pif. Clearly, the hyperplastic network of 
initial lymphatics deriving from overexpression of VEGF-C resulted in a strongly 
enhanced lymphatic vessel area, that will enhance the fluid uptake and 
accordingly lymph transport in response to pressure gradients. Lymph flow might 
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have been influenced by a difference in structure and thus resistance in 
downstream lymph nodes, but that is not likely because of our finding of similar 
structure and area of lymph node sinusoids in K14-VEGF-C and WT mice(208). 
The fact that the lymph flow was higher in transgenic than in WT mice for the same 
Pif gradient suggests that lymphangiogenesis results in reduced resistance against 
lymph formation.  
 
VEGF-C gene therapy – clinical implications 
The present study shows the importance of a functional evaluation of a 
morphological phenotype resulting from genetic modifications, and may have 
implications for therapy of lymphatic disorders. The lack of effects when inducing 
inflammation likely reflects that lymph drainage can be modulated downstream 
of the initial lymphatics, as discussed above. Additional knowledge on such 
downstream mechanisms is needed when considering the potential benefits of 
VEGF-C induced lymphangiogenesis in humans. Our findings of facilitated initial 
lymph formation and enhanced chemokine production after lymphangiogenesis 
may explain the previously observed favorable effects of VEGF-C in inflammatory 
edema and lymphedema therapy. Karkkainen et.al. used adenovirus-mediated 
VEGF-C gene therapy, and could generate functional lymphatic vessels that 
reduced swelling in a mouse model of primary lymphedema(155). Transgenic 
overexpression of VEGF-C moreover inhibited chronic skin inflammation and 
reduced edema in a mouse model(178), and attenuated joint tissue damage(209). 
In addition, VEGF-C treatment has been shown to be important in forming both 
afferent and efferent connections with the preexisting lymphatic vessel network, 
and to result in improved postoperative lymph drainage and enhanced survival 
and functionality of transferred lymph nodes, suggesting that VEGF-C therapy may 
be beneficial to counteract postoperative lymphedema(210). It has been 
suggested that VEGF-C might act as an endogenous counter-regulatory 
mechanism for limiting edema formation and inflammation(178), but facilitated 
initial lymph formation and enhanced chemoattractant production by lymphatics 
as shown here is a potential common explanation for the therapeutic effect. 
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 Studies on the functional consequences of a chronically expanded 
lymphatic network or lymphangiogenesis are few and the results are 
diverging  
 We used K14-VEGF-C transgenic mice overexpressing the vascular 
endothelial growth factor C in skin, and investigated the responses to 
inflammatory and fluid volume challenges  
 Acute and chronic inflammation resulted in increased interstitial fluid 
pressure and reduced lymph flow, both to the same extent in wild type 
and transgenic mice.  
 Hyperplastic lymphatic vessels demonstrated enhanced transport 
capacity after local fluid overload not induced by inflammation  
 Lymphangiogenesis may facilitate initial lymph formation favoring 











Figure 1.  The lymphatic network is enlarged in K14-VEGF-C mice. (A) 
Representative whole-mount staining of LYVE-1+ lymphatic capillaries and 
CD31+ blood vessels in ears from WT and K14-VEGF-C mice. Scale bar = 200 µm. 
(B) Quantification of lymphatic (left) and blood vessel (right) area in ear skin of 
WT and K14-VEGF-C mice. Four areas from each ear whole-mount preparation 
were counted per mouse. The LYVE-1+ lymphatics and CD31+ blood vessels 
where manually encircled and area calculated in ImageJ. (C) Serial sections (10 
µm) from intact paw (left) and back skin (right) of WT and K14-VEGF-C stained 
for LYVE-1. LYVE-1+ lymphatic vessels were manually encircled in three sections 
from each mouse and total area per mm dermis calculated. Mean ± SEM, n=5-6. 




Figure 2. Lymph flow is impeded to a similar extent in WT and K14-VEGF-C mice 
in response to inflammation. (A) Average Loge fraction of counts remaining in 
the intradermally injected depot of the fluorescent macromolecular tracer Alexa-
680 BSA in hind paw of WT and K14-VEGF-C mice during basal conditions. (B) 
Extravasation of the radioactive macromolecular tracer 125I-HSA (human serum 
albumin) from the vasculature into paw and back skin of WT and K14-VEGF-C 
mice after 30 min during basal conditions. Five min extravasation of 125I-HSA 
was subtracted from these values to correct for any 125I-HSA present in the 
vasculature of the excised tissue at 30 min. (C) Rate constants (k) calculated by 
determining the slope of the individual wash-out curves for WT and K14-VEGF-C 
mice during basal conditions, after oxazolone-induced hypersensitivity response 
(day 7) or after intradermal injection of 2 µl LPS (4 µg/µl).  (D) Fraction of 
counts remaining in the intradermal depot in hind paw of WT and K14-VEGF-C 
mice 24 hours after injection of a mixture of either 2 µl isotonic saline (control 
group) or 2 µl LPS (4 µg/µl) both in combination with 1 µl Alexa680-BSA. Mean ± 




Figure 3. Interstitial driving forces for lymph formation are enhanced to a 
similar extent in WT and K14-VEGF-C in response to inflammation. Total tissue 
water in hind paw skin (A) and ear (B) of WT and K14-VEGF-C mice in response 
to oxazolone-induced hypersensitivity response or to acute inflammation 
induced by intradermal injection of LPS (4 µg/µl). Interstitial fluid pressure in 
hind paw skin (C) or ear (D) of WT and K14-VEGF-C mice in response to 
oxazolone-induced hypersensitivity response or to acute inflammation induced 
by intradermal injection of LPS (4 µg/µl). Mean ± SEM, n=4-10. *p˂0.05, 




Figure 4. Intradermal overhydration enhances lymph formation to a greater 
extent in K14-VEGF-C mice. (A) Average Loge fraction of counts remaining in the 
intradermally injected depot of 0.5 µl Alexa680-BSA in hind paw of WT and K14-
VEGF-C mice during a control period (60-180 min) and after an intradermal 
injection of 30 µl isotonic saline into the same hind paw (180-300 min). (B) Rate 
constants (k) calculated by determining the slope of the individual wash-out 
curves for the time period after intradermal saline injection (180-300 min) by 
linear regression analysis. (C) Interstitial fluid pressure measured in hind paw 
skin of WT (n=6) and K14-VEGF-C (n=7) mice in control situation and at 
different time points after an intradermal injection of 30 µl isotonic saline 




Figure 5. Reduced lymph formation in vegfr3 mutant Chy mice with skin 
lymphatic vessel hypoplasia. (A) Average Loge fraction of counts remaining in the 
intradermally injected depot of 0.5 µl Alexa680-BSA in hind paw of WT and Chy 
mice during a control period (60-180 min) and after an intradermal injection of 
30 µl isotonic saline into the same hind paw (180-300 min). (B) Rate constants 
(k) calculated by determining the slope of the individual wash-out curves for the 
time period after intradermal saline injection (180-300 min) by linear regression 
analysis. (C) Interstitial fluid pressure measured in hind paw skin of WT (n=4) 
and Chy (n=4) mice in control situation and at different time points after an 
intradermal injection of 30 µl isotonic saline (arrow). Mean ± SEM, n=4-6. 




Figure 6. Increased amount of the immune cell attractant CCL21 in K14-VEGF-C 
mice (A) Representative whole-mount co-staining of LYVE-1+ lymphatic 
capillaries and CCL21 in ears from WT and K14-VEGF-C mice. Scale bar = 200 
µm. (B) Quantification of total CCL21 counts per field of view. (C) Proportions of 
CCL21 counts per LYVE-1+ lymphatic vessel area. The LYVE-1+ lymphatics where 
encircled and area calculated while lymphatic CCL21 staining was counted 




Figure 7. Unaltered dendritic cell mobilization from skin to lymph nodes in K14-
VEGF-C mice in response to FITC painting. (A) Representative epidermal sheets 
double-stained for the Langerhans cell marker CD207 and MHC-II. Scale bar = 50 
µm. (B) Quantification of CD207+MHC-II+ Langerhans cells in epidermal sheets of 
WT and K14-VEGF-C mice. (C) Proportions of FITC+MHC-II+CD11c+ dendritic 
cells in lymph nodes of WT and K14-VEGF-C mice 18 h after FITC painting. Mean 
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Abstract 
Objective: A commonly accepted pivotal mechanism in fluid volume and blood pressure 
regulation is the parallel relationship between body Na+ and extracellular fluid content. 
Several recent studies have, however, shown that a considerable amount of Na+ can be 
retained in skin without commensurate water retention.  Here we asked whether a salt 
accumulation shown to result in VEGF-C secretion and lymphangiogenesis had any 
influence on lymphatic function.  
Approach and Results: By optical imaging of macromolecular tracer washout in skin we 
found that salt accumulation resulted in an increase in lymph flow of 26% that was 
noticeable only after including an overnight recording period. Surprisingly, lymph flow in 
skeletal muscle recorded with a new PET/CT method was also increased after salt 
exposure. The transcapillary filtration was unaffected by the high salt diet and 
deoxycorticosterone-salt treatment, suggesting that the capillary barrier was not 
influenced by the salt accumulation. A significant reduction in lymph flow after depletion 
of macrophages/monocytes by clodronate suggests these cells are involved in the 
observed lymph flow response, together with collecting vessels shown here to enhance 
their contraction frequency as a response to extracellular Na+.  
Conclusions: The observed changes in lymph flow suggest that the lymphatics may 
influence long term regulation of tissue fluid balance during salt accumulation by 
contributing to fluid homeostasis in skin and muscle. Our studies identify lymph clearance 
as a potential disease modifying factor that might be targeted in conditions characterized 
by salt accumulation like chronic kidney disease and salt-sensitive hypertension. 
 
Key words: blood pressure; hypertension; body water; extracellular fluid; extracellular 
matrix; lymph flow, sodium. 
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Introduction 
A commonly accepted pivotal mechanism in fluid volume and blood pressure 
regulation is the parallel relationship between body Na+ and extracellular fluid 
content(211).  To maintain blood pressure homeostasis, body fluid volume, and thereby 
body Na+ content, has to be maintained within very narrow limits. Several recent studies 
in humans have, however, shown that a considerable amount of Na+ is retained or 
removed from the subjects’ bodies without a corresponding water retention or loss(147-
149, 212) that would have been predicted if the extracellular fluid volume was 
determined by the amount of body Na+ only. These observations suggest that Na+ could 
be stored somewhere in the body without commensurate water retention, and thereby be 
inactive from a fluid balance viewpoint, e.g.(9), also implying that unidentified extrarenal, 
tissue-specific regulatory mechanisms might control the release and storage of Na+ from 
a kidney-independent reservoir. Later studies have indicated that skin might serve as a 
major Na+ reservoir, e.g.(12, 213-215), again suggesting that there might not be strict 
isotonicity of all body fluids, and that skin electrolyte concentrations do not necessarily 
equilibrate with blood electrolytes. One consequence of such electrolyte accumulation in 
excess of water would be that it might cause local hypertonicity. Indeed, using vapor 
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pressure osmometry we recently demonstrated that Na+ accumulation in skin as a 
consequence of feeding rats a high-salt diet (HSD) results in a tissue that is hyperosmotic 
relative to plasma(13).  
Because of the demonstration of its role in salt storage and buffering discussed 
above, the skin is a potential actor in blood pressure regulation. Mice and rats fed HSD 
develop hypertension and have a hyperplastic lymphatic capillary network in the skin 
induced by VEGF-C secreted by mononuclear phagocyte system (MPS) cells(11, 13). 
Blocking the ability for lymphangiogenesis results in an increased blood pressure 
response to salt loading(13). An unresolved and central question is whether such HSD-
induced lymphangiogenesis results in increased lymph flow, i.e. whether the vessels are 
functional. We therefore asked if the Na+ concentration dependent lymph vessel 
hyperplasia has functional importance. To this end we decided to assess the importance 
of lymphatic vessel phenotype for fluid drainage, and whether lymph flow is actually 
increased in rats with hypertension induced by HSD or deoxycorticosterone (DOCA) 
treatment using a recently developed optical imaging technique(158). We also assessed 
how skin lymphatic collectors, studied ex vivo, would respond to elevated Na+. Moreover, 
since Na+ also appear to accumulate in skeletal muscle in hypertensive patients(153), we 
asked if such accumulation also influenced fluid drainage in muscle, and developed a 
positron emission tomography-computed tomography (PET/CT) method to be able to 
assess lymph flow in deeper structures.  
Collectively, the present results indicate that the newly formed lymphatics induced 
by salt accumulation either by HSD or DOCA are functional. Moreover, our data suggest 
that existing and newly formed lymph vessels contribute to blood pressure control and to 
the previously observed attenuation of the rise in blood pressure in models of salt 
sensitive hypertension.  
Materials and Methods 
The data that support the findings of this study are available from the corresponding 
author upon reasonable request. 
Ethical approval.  All animal experiments were conducted in accordance with the 
regulations of the Norwegian State Commission for Laboratory Animals, harmonized to 
be in accordance with the European Convention for the Protection of Vertebrate Animals 
used for Experimental and Other Scientific Purposes and Council of Europe (ETS 123), 
and with approval from the AAALAC International Accredited Animal Care and Use 
Program at University of Bergen. All mouse protocols were approved by the University of 
Missouri Animal Care and Use Committee and conformed to the US Public Health Service 
policy for the humane care and use of laboratory animals (PHS Policy, 1996). 
Animals. We used mice and rats. The animals were of male sex only because background 
data for the hypothesis to be tested were derived from this sex only. Mice (C57Bl/6), 
weighing between 18 and 22 g, were obtained from Jackson Laboratories (JAX, USA) and 
used for isolation of skin lymphatic collecting vessels (please see the Major Resources 
Table in the Supplemental Material). NTac Sprague Dawley rats were from Møllegaard 
Breeding Colony, Skensved, Denmark, weighing between 150-200 g at the start of the 
experiment. The rats were randomly assigned into three groups with different diet 
regimes; group low salt diet (LSD) received low salt chow (< 0.1% NaCl) and tap water; 
group HSD received high salt chow (8% NaCl) and 1 % saline drinking water; group DOCA 




a deoxycorticosterone acetate (DOCA) tablet (100 mg/pellet, Innovative Research of 
America) in the neck region. In a separate set of experiments the three different diet 
groups were treated with intraperitoneal injections of 1 ml clodronate liposomes (5 
mg/ml Clodrosome, Encapsula Nanosciences) every 4th day, at day 0, 4, 8 and 12.   
After 2 weeks on diet blood pressure was measured in all groups with a non-
invasive tail cuff system (CODA-6, Kent Scientific, Torrington, CT) and further 
experiments conducted as described below.  
During experiments the rats were either anesthetized with 3% isoflurane (DOCA 
pellet implantation, optical imaging and extravasation) or 2% sevoflurane (PET/CT) both 
in 100% O2. The body temperature was maintained at 37°C while under anesthesia.  The 
experiments were terminated by excising the heart while under deep anesthesia.  
 Mice were anesthetized with an intraperitoneal injection of sodium pentobarbital 
(60 mg/kg). After anesthesia, an incision was made near the midline of the lower back 
and the skin covering the left rear flank was retracted to the side. A segment of the afferent 
lymphatic draining the skin and feeding into the inguinal lymph node fat pad was cleared 
of loose connective tissue, and excised. 
 
Preparation of radiolabeled probes.  Human serum albumin (HSA) (Albunorm, 
Octopharma, 200 mg/ml) was labeled with 125I and 131I (for extravasation studies) or 124I 
(for PET/CT) by Iodo-Gen as described in detail previously(216). 
 
Albumin extravasation.  Blood-to-tissue clearance of albumin in hind paw skin and thigh 
muscle was determined as the difference between the 35 and 5 min plasma equivalent 
space of 125I-HSA and 131I-HSA, respectively, as described in detail elsewhere(217). 
 
Optical imaging.  To assess lymph flow in skin we monitored the depot clearance of an 
intradermally injected near-infrared macromolecular tracer with time by optical imaging 
as described in detail previously(158).  
 
PET/CT scanning.  To assess lymph flow in muscle we developed a PET/CT method. 124I-
HSA (3 µl) was injected into thigh muscle with a graded Hamilton syringe. PET and CT 
scans (small-animal PET/CT, NanoScan PC PET/CT; Mediso Ltd, Budapest, Hungary) were 
performed 1, 3, 5, 7 and 22 hours post-injection to determine the clearance of 
macromolecular tracer from the injected area. The rats were awake and freely moving in 
between scans to facilitate lymph flow.  First, a CT scan was performed to obtain 
anatomical information and for attenuation correction, with the following acquisition 
parameters: Helical scan, 70 kVp, 300 ms, Projections: 360 and reconstructed using Shepp 
Logan filter. Directly thereafter a 10 min per bed position PET scan was performed with 
acquisitions parameters as follows: field of view (FOV) 9.6 cm in the axial direction and 
10 cm in the transaxial direction, 1:5 coincidence mode and normal count rate mode. The 
body temperature was maintained at 37 degrees throughout the whole procedure. 
Reconstruction of the PET data was performed with 3D OSEM and 1:3 coincidence mode, 
no filtering, attenuation correction, decay correction and normalization of detectors. The 
images were analyzed using Interview fusion software (version 2.02.029.2010 BETA) and 
number of photon counts calculated for each region of interest. For the determination of 
removal rate constants (k), the natural logarithm of the fractional amount of counts 
remaining at the injection site was plotted against time. The resultant monoexponential 




curve for each animal. The rate constant for each animal was calculated as the slope of the 
curve, as previously described(158). 
 
Chemical analysis of tissue electrolytes and water content.  Chemical analysis of tissue 
electrolytes and water content was performed as described in detail previously(13). 
 
Immunohistochemistry frozen sections. Frozen sections from 4% PFA fixed and sucrose 
dehydrated ears were incubated in 0.3% H2O2 in methanol, before blocking in goat serum, 
both for 30 min (please see the Major Resources Table in the Supplemental Material). 
Rabbit anti-mouse/rat lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) 
primary antibody (1:100, Novus Biologicals) in blocking serum was added for an 
overnight incubation at 4°C. Thereafter, secondary antibody (goat anti-rabbit; 1:200, 
Vector Laboratories Inc.) in blocking serum was added for 30 min before incubating with 
avidin-biotin complex (Vectastain ABC kit – peroxidase Rabbit IgG PK.4001, Vector 
Laboratories Inc.). Bound antigen was visualized using 3,3’-diaminobenzidine (Sigma 
Aldrich) in combination with nickel. To validate antibody specificity staining was 
compared to negative controls run with rabbit IgG (Merckmillipore) replacing the 
primary antibody. The quantification was performed blindly, counting LYVE-1+ vessels 
from 5-6 consecutive fields of view (20 x magnification, 3 rats per group). 
 
Immunohistochemistry paraffin sections.  Ears were fixed overnight in 4% PFA before 
paraffin embedding and sectioning. After deparaffinization, antigen retrieval was 
performed in Daco Target Retrieval solution pH 9 for 30 min at 98°C. Sections were 
blocked in horse serum and bovine serum albumin for 30 min, before overnight 
incubation at 4°C with mouse anti-rat CD68 primary antibody (1:100, Abcam) in blocking 
solution (please see the Major Resources Table in the Supplemental Material). After 
incubation in 0.3% H2O2 for 30 min, secondary antibody (horse anti-mouse; 1:200, Vector 
Laboratories Inc.) in blocking solution was added for another 30 min. The sections were 
reacted with avidin-biotin complex (Vectastain ABC kit, Vector Laboratories Inc.) for 30 
min and bound antigen visualized using diaminobenzidine substrate kit (Abcam). To 
validate antibody specificity staining was compared to negative controls run with mouse 
IgG (Merckmillipore) replacing the primary antibody. The quantification was performed 
blindly, counting CD68+ cells from 4 consecutive fields of view (60 x magnification, 4 rats 
per group).  
 
Contractility of isolated mouse afferent skin lymphatics.  The excised segment of afferent 
lymphatic was placed in 145 Na+ Krebs solution + 0.5% bovine serum albumin, cleaned of 
fat and connective tissue and cannulated at each end with a micropipette as described 
previously(218) (for composition of solutions used in contractility experiments please 
see the Major Resources Table in the Supplemental Material). Pipettes contained 145 Na+ 
Krebs + 0.5% bovine serum albumin. The vessel, bath chamber and pipette holders were 
mounted onto the stage of an inverted microscope and connected to independent 
pressure controllers (219). The vessel equilibrated at 37oC for 60-90 minutes, at 3 cmH2O, 
with the bath was exchanged with 145 Na+ Krebs solution (0.5ml/min). Video and data 
acquisition were the same as described previously(219).  
 
Protocols used in contractility assessment.  Spontaneous contractions typically began 
within 15 minutes. Pressure was stepped through a physiological range of pressures, 0.5 




for 2-3 minutes at each pressure. Input and output pressures were equal at all times so 
that there was no net gradient for flow that might influence the contraction pattern due 
to production of endothelial nitric oxide(220). The bath was exchanged with 165 or 185 
Na+ Krebs solution or 40 or 80 mosm urea solution and allowed to equilibrate for 60 
minutes after which another set of pressure steps was imposed. Afterwards the bath was 
exchanged with Ca2+ free Krebs solution for 20 minutes and the passive diameter of the 
vessel was recorded at each of the different pressures used. 
After the experiment, end systolic and diastolic diameters (ESD and EDD, 
respectively) were determined for each individual spontaneous contraction at each 
pressure level.  Contraction frequency (FREQ) was computed on a contraction-by-
contraction basis and the following contraction parameters were calculated: 
Amplitude = EDD – ESD                                                         (1)  
Tone (%) = [(MaxD – EDD)/MaxD]*100                              (2) 
Ejection Fraction = (EDD2 – ESD2)/EDD2                     (3) 
Fractional Pump Flow = FREQ*EF                                        (4) 
MaxD was the maximum passive diameter obtained in Ca2+-free Krebs solution at 
each respective pressure. The average of each of the parameters was determined over 
each 2-3-minute interval at each pressure and the values were tabulated in Excel to 
produce the summary graphs. 
 
Data analysis and statistics. Data and statistical analysis was performed using GraphPad 
PRISM Version 7.0. All data passed normality and equal variance tests, therefore 
parametric two-tailed t-tests were chosen to compare two groups while differences 
between multiple  groups were assessed by analysis of variance (ANOVA) followed by 
Dunnett’s or Bonferroni’s multiple comparisons test as specified in the figure legends.  
Values are given as mean  SD, and p < 0,05 % was considered statistically significant. 
 
Results 
Establishment of models of salt sensitive hypertension  
Here we applied the same models as those used in a recent study by us(151) and 
previously by Titze and collaborators to induce skin salt accumulation and that have been 
shown to be accompanied by lymphangiogenesis in skin, i.e. feeding a high salt diet 
(HSD)(11) and the DOCA-salt model without uni-nephrectomy(12).  
 Blood pressure as measured with the tail cuff method at the initiation of HSD or 
DOCA treatment (day 0), was not different between rats assigned to LSD, HSD and DOCA-
salt groups (data not shown). Figure 1A shows collected mean arterial pressures for all 
the rats included in the study, and we observed that HSD as well as DOCA-salt induced an 
increase in mean blood pressure averaging 18 and 51 mm Hg compared with LSD, 
respectively. This corresponds well with our own recently published data(151) and with 
previous reports employing the same models but where blood pressure was measured 
with a catheter in awake animals(11, 12).  
 In a subset of rats, we investigated whether the HSD and DOCA-salt treatment 
resulted in salt and fluid accumulation in skin. Skin water content assessed by drying until 
the weight stabilized tended to be increased in HSD compared with LSD, but the increase 
was statistically significant only in DOCA-salt rats, averaging 19% (Fig 1B). There was, 
however, a significant increase in Na+ content relative to water (Fig. 1C) as well as Na+ 
content relative to dry weight (Fig. 1D) in HSD and DOCA-salt treatment compared with 
the LSD group, in line with corresponding data in own(151) as well as previous 




 To investigate whether our high salt models also led to an increased 
lymphangiogenesis we stained for LYVE-1 in skin (Fig 1E). As shown in Fig 1F, the lymph 
vessel number was increased in HSD and DOCA-salt fed rats in agreement with previous 
studies(11).  
 
Salt accumulation induces increased lymph flow in skin 
 To assess whether the lymphangiogenesis in skin induced by HSD and DOCA-salt 
treatment had an influence on lymph flow we used an optical imaging method based on 
washout of the near infrared probe Alexa680 bound to albumin(158). With this method, 
the rate constant of the washout will reflect lymph flow. Washout curves for LSD, HSD and 
DOCA-salt are shown in Fig 2A and the corresponding rate constants for the washout in 
Fig 2B. The slopes of HSD and DOCA-salt washout curves were significantly different from 
that of LSD, suggesting an increased lymph flow under high salt conditions (Fig 2A). 
Although the average washout of tracer was faster and thus the rate constants for HSD 
and DOCA-salt were 27 and 33% higher (more negative value), and might indicate a 
higher lymph flow, particularly for the DOCA-salt group as shown by the p=0.058 when 
compared with LSD, these rate constants were not significantly different (Fig. 2B).  
 To increase the sensitivity of the analysis, and also include the night time in the 
washout period when the rat is more active, we recorded the tracer remaining in the 
depot 22 h after injection (Fig. 2C). In this analysis, we included all animals that were 
employed in the study, also those from subgroups that were used as controls in the 
clodronate experiments (see below). Whereas on average 24% of the tracer remained in 
the LSD group, the corresponding fraction averaged 19% in the HSD as well as the DOCA 
group, both significantly lower than in the LSD group (p<0.01 for both comparisons) (Fig. 
2C). This shows that with increased resolution of the tracer washout, we were able to 
demonstrate an increased lymph flow in both of the groups that accumulated salt.  
 
Lymph flow in muscle increased as recorded with PET 
 Recent studies have indicated that Na+ appears to accumulate in both skin and 
skeletal muscle in hypertensive patients(153).  We therefore asked whether such 
accumulation also influenced lymph drainage in muscle. Since photons emitted by 
fluorescent probes are absorbed in tissues to a higher extent than radionuclides, we 
decided to develop a PET-CT method to be able to assess lymph flow in the deeper 
positioned muscle. By labeling human serum albumin with 124I we could, as for optical 
imaging, record washout of radioactive tracer and thereby lymph flow in muscle.  
As shown by HPLC, we made a macromolecular probe that after labeling was 
inseparable from the native substance and without any free tracer that might have been 
taken up by the capillaries and thus led to an overestimation of the tracer washout rate 
(Fig 3A). An example of original recordings of tracer washout in one rat at different time 
points is shown in Figure 3B, and a summary of tracer washout for LSD and HSD in Fig. 
3C. The rate constants (k-values) for muscle were not different between the LSD and HSD 
(Fig. 3D) when recorded in intermittent sessions during day-time. As for skin, we also 
recorded the tracer remaining 22h after injection in muscle. Interestingly, we found a 
subtle, but statistically significant difference between LSD and HSD, inasmuch as 15 and 
12% of the tracer (p<0.05) remained in skeletal muscle 22 h post injection (Fig 3E), 
suggesting that the high-salt diet increases lymph flow in muscle as well as in skin.  
 




 In a steady-state situation with no fluid accumulation, the net amount of fluid 
filtered across the capillaries will be taken up and removed by lymphatics. Because we 
found that the lymph flow was increased in skin and muscle, we estimated the fluid 
extravasation in paw skin and thigh muscle using the double isotope tracer technique for 
all groups in skin and for LSD and HSD in muscle. As can be seen from Figure 4, there was 
no difference in extravasation in either tissue (Figure 4 A,B). A similar protein 
extravasation in HSD and LSD indicates that the endothelial barrier is intact in the HSD 
situation, and that the increase in lymph flow in high salt conditions is not a result of an 
influence of salt on the endothelial barrier.  
 
Effect of blocking MPS-cells by clodronate  
 Previous studies have shown that depletion of MPS-cells with clodronate prevents 
the lymphangiogenesis induced by salt accumulation and increases the blood 
pressure(11, 12). To confirm that skin MPS cells were depleted in response to clodronate 
in our experiment we stained with the MPS cell marker CD68 in skin sections from LSD, 
HSD and DOCA-salt rats with or without such treatment (Fig 5A). CD68+ MPS cells 
increased significantly in skin after HSD, but not after DOCA-salt diet, while clodronate 
treatment reduced the number of CD68+ cells below basal levels in all the three diet 
groups (Fig. 5B). To assess whether such MPS-cell blockage also influenced the drainage 
of fluid from the tissue, we measured clearance of tracer with optical imaging in skin 
following clodronate administration in all group of rats (Fig 5C). Although the average 
rate constant, k, after clodronate treatment was slightly higher in HSD and DOCA-salt rats 
indicating a reduced lymph flow, this difference was statistically significant in the DOCA 
group only (Fig. 5C).  
 We then measured the amount of tracer remaining of the injected depot after 22 h 
i.e. including an overnight washout period, and found that more tended to remain in the 
HSD and DOCA-salt rats after clodronate treatment when compared with the 
corresponding control fraction. The remaining fractions after clodronate were 
significantly different from their respective controls for HSD and DOCA-salt, whereas 
clodronate treatment had no effect in the LSD group. This finding suggests that the 
depletion of MPS cells resulted in a dysfunction of the lymphatics under high salt 
conditions and a reduced clearance function (Fig 5D).  
  
Increased contraction of lymphatics in high salt environment 
 Based on our finding of an increase in lymph flow in rats with salt accumulation in 
skin interstitium we asked whether this affected the contraction properties of the small 
lymph collecting vessels. To this end we isolated and cannulated afferent lymph vessels 
from normal mouse skin (Fig 6A), and examined these under conditions where the 
external salt concentration was enhanced but where the intravascular buffer was 
isosmotic with plasma. Example recordings showing the pattern of spontaneous 
lymphatic contractions at each level of pressure (0.5 to 10 cmH2O) in 145 mM Na+ Krebs 
solution and 185 mM Na+ Krebs solution are shown in Fig. 6B,C. Each downward 
deflection represents a single contraction lasting 3-5 sec. Pin and Pout are the pressures 
set by the input and output cannulas, respectively, and were equal throughout the 
pressure step protocol. Lowering pressure in steps from 3 to 0.5 cmH2O resulted in a 
slowing of spontaneous contraction frequency and an increase in contraction amplitude 
at 1 and 2 cmH2O but a decrease in amplitude at 0.5 cmH2O; raising pressure from 0.5 to 
10 cmH2O resulted in an increase in frequency and decrease in amplitude such that only 




consistent with those reported previously for lymphatic collectors from both rat 
mesentery and other peripheral regions of the mouse(219, 220). Exposure of the vessel 
to 185 mM Na+ Krebs solution produced increases in frequency and slight decreases in 
amplitude at all pressures (Fig 6C). 
Results from 5 vessels exposed to both 145, 165 and 185 mM Na+ Krebs solutions 
have been summarized in Fig. 6D,E and Supplemental Fig. I. For contraction frequency 
and fractional pump flow there was a dose-dependent effect of Na+ in the Krebs buffer 
solution surrounding the vessel (Fig. 6D,E), whereas for amplitude, ejection fraction and 
vessel tone there was no difference between the groups. Replacing the additional Na+ with 
urea to obtain a similar osmolality had no effect on any of the recorded parameters (Fig. 
6D,E and Supplemental Fig. II). Therefore, exposure of the adventitia of the collecting 
vessel to a hypertonic solution that has a tonicity in the upper range of what might be 
expected after HSD and DOCA-salt treatment resulted in increased contraction frequency 
that was most pronounced at high pressures as well as pump flow at low pressures. An 
increased pumping may thus be part of the explanation for the observed rise lymph flow. 
 
Discussion 
The major question asked in the present study was whether the salt accumulation 
shown to result in macrophage accumulation and lymphangiogenesis had any influence 
on lymphatic function. Here we found that high salt conditions resulted in an increase in 
lymph flow that was detectable only after including an overnight recording period. We 
moreover developed a PET-CT method to assess lymph flow in skeletal muscle, and 
observed that lymph flow was increased after salt exposure in muscle too. Ex vivo studies 
of isolated afferent collecting vessels suggested that a high interstitial concentration of 
Na+ gave more frequent contractions, without a significant compromise in contraction 
amplitude, that might contribute to the observed flow increase. The transcapillary 
extravasation of albumin was unaffected by the HSD treatment, indicating that the 
capillary barrier was not influenced by the salt accumulation. A significant reduction in 
lymph flow after depletion of macrophages by clodronate indicates that these cells are 
involved in the observed lymph flow response. The enhanced tissue fluid clearance 
suggests that the lymphatics may contribute to long term regulation of tissue fluid balance 
during salt accumulation by contributing to electrolyte and fluid homeostasis in skin and 
muscle. 
 
Evaluation of methods and limitations 
 To assess lymph flow in skin we used a sensitive and minimally invasive optical 
imaging method that we have validated in a recent paper(158). One limitation regarding 
optical imaging is photon absorption in the tissue. This stimulated us to develop a PET-
CT based method that is not limited by tissue depth(221) to be able to record reliably 
from the deeper structures like muscle that, similarly to skin, has been shown to 
accumulate Na+ in hypertensive patients(153).  
To our knowledge, PET-CT has not been used to monitor lymph flow previously, 
but has been applied to visualize inflammation and tumor-induced lymph node 
lymphangiogenesis by i.v. injection of a PET-probe targeting lymphatic-specific 
epitopes(222). Clearly, PET-CT is an expensive and labor-intensive method, but we 
present a new and valuable alternative for recording of lymph flow that can be used in 
several species, including mice, when recordings from deeper structures are required.  
Our use of mouse afferent lymphatics from skin to determine contraction 




limitation of the relevance to all the other data obtained from rats. It should be noted 
though, that mouse and rat lymphatics have been found to respond similarly in 
comparable experiments ex vivo(219, 220) and in vivo(223). Importantly, in a recent 
comprehensive study, it was concluded that peripheral lymph vessels, as studied by us, 
from mice and rats respond similarly to contraction stimuli(224). Moreover, in 
preliminary experiments we have results indicating that peripheral rat vessels respond 
similarly as mouse vessels when exposed to high salt conditions. Together, these studies 
suggest that the present contraction data obtained from mouse vessels are relevant also 
for rats. Moreover, these lymph vessel contraction data are also relevant because much of 
the work having shown a role of skin lymphatics in blood pressure regulation originate 
from mice(11, 13). 
 
Comparison to previous studies 
 In a recent study, Kwon et al(223) have tried to assess lymphatic contractile 
function in rats and mice after induction of hypertension with HSD. By using indocyanine 
green, they were able to show dilated vessels having an increased contractility in the HSD 
animals, a contractility response pointing in the same direction as our ex vivo results. 
Their contraction frequency response was however quite dramatic, amounting to ≈200% 
after 14 days of HSD in both species. Such an increment is surprising considering the 
modest augmentation needed to provide for the subtle change in lymph flow found in the 
present study. It is possible that the rather large volume of indocyanine green needed for 
the imaging of the hindlimb (10 and 50 l, the amount not specified in the various 
experiments), volumes shown by us to increase lymph flow(217), might have influenced 
these results.  
 The present models for hypertension, HSD and DOCA-salt feeding, are 
characterized by generation of VEGF-C, which also has a potential effect on contractility 
of lymphatic collectors. Breslin et al(225) superfused rat mesentery lymphatics with 
VEGF-C and found an increased lymphatic pumping mediated through VEGFR-3. Although 
the dose they chose was based on data from humans, it apparently was sufficient to 
augment the capillary permeability in the mesenteric circulation. Since the albumin 
extravasation in skin and muscle was unaltered in high salt conditions in our experiments, 
it seems unlikely that VEGF-C contributed to the lymph flow effect that we observed. 
 
Implications of findings 
 Ever since the demonstration that HSD induces mononuclear phagocyte system 
(MPS) cell accumulation, VEGF-C secretion and subsequent lymphangiogenesis(11), a 
crucial question has been what the functional consequence of such lymphangiogenesis 
are, adding to the more general question of “what lymphangiogenesis achieves”(203). 
Apparently, both blocking of the MPS-cell accumulation by clodronate during salt loading 
and inhibiting the lymphatic hyperplasia(11, 12), as well as curbing the ability for 
lymphangiogenesis by the use of a VEGF-C receptor trap mouse model(13) or an 
angiogenesis inhibitor(186), have resulted in hypertension. These studies suggest that 
lymphangiogenesis has a role in blood pressure control in high salt conditions. The 
question then is whether the lymph capillary network has an integral role in the 
maintenance of interstitial electrolyte and volume homeostasis as recently proposed(11).  
 With regard to electrolyte homeostasis, if the lymphatics were to contribute one 
might think that the concentration of electrolytes and other osmolytes would be higher in 
lymph draining skin that is hyperosmotic due to salt accumulation. In HSD and DOCA-salt 




control LSD rats(151), showing that there is no gradient between interstitium and lymph. 
Still, given the same electrolyte concentration in lymph in LSD on one hand and HSD and 
DOCA-salt on the other, an increased lymph flow in the high salt groups would transport 
more electrolytes from the tissue and thus contribute to clearance of osmolytes and 
electrolytes from tissues with accumulated salt. This mechanism, possibly assisted by 
increased lymphatic pumping due to a hyperosmotic interstitium as indicated by our 
experiments, may contribute to the maintenance of electrolyte homeostasis. Our finding 
of a subtle increase in lymph flow that was first recognized after long-term observation 
in a period where the rats are more active thereby suggests that an enhanced clearance 
of fluid from the tissue is an integrated element of this homeostasis.  
 There are, indeed, clinical data that support the hypothesis that the lymphatics are 
influencing disease development. In end stage renal disease patients undergoing 
hemodialysis, Dahlmann et al(226) measured Na+ in skin and muscle and observed an 
increase content with age. Interestingly, there was a reduction in VEGF-C with age, and 
thus an inverse relation to Na+ in skin and VEGF-C in plasma. They proposed that the 
lower VEGF-C levels could reduce the Na+ clearance and lead to Na+ accumulation in the 
skin. Even though we do not know whether the reduced VEGF-C results in reduced 
pumping efficiency, insufficient lymphangiogenesis or reduced lymph flow, these data 
clearly point to lymphatic function as an important factor in Na+ homeostasis and a 
disease modulating factor. This factor might be targeted in other conditions characterized 
by salt accumulation such as chronic kidney disease and hypertension(153, 226). 
 In spite of significant salt accumulation, the water accumulation was modest. It is 
therefore likely that the interstitial fluid volume was in steady state at the time of study. 
The extravasation experiments suggest that the capillary permeability and thereby the 
integrity of vessel wall was not changed by the high salt intake that has been proposed to 
induce an inflammatory reaction(227). With an intact vessel barrier and no (HSD) or 
limited fluid accumulation (DOCA), we may assume a transcapillary filtration equal to that 
of lymph flow, and thus a higher filtration when recorded over a longer period involving 
the night.  
 
To summarize, here we have been able to address the question “what lymphangiogenesis 
achieves”(203) in a situation where salt accumulation results in a hyperosmotic 
interstitium with macrophage accumulation, VEGF-C production and ensuing 
lymphangiogenesis. Accumulation of salt resulted in an increase in lymph flow of 26 and 
20% from skin and muscle, respectively, and was first recognized after long-term 
observation. Such increase is likely the result of a corresponding enhanced filtration of 
fluid in combination with an increased contraction frequency of lymphatic collectors. 
Although this increase in flow might appear modest, we must remember that the 
transport of Na+ (and other ions) from these tissues back to the general circulation will 
increase correspondingly, and suggests that an enhanced clearance of fluid from the 
tissue is an integrated element of electrolyte homeostasis and a regulatory mechanism 
working over long time. These studies point to the importance of lymph flow as a potential 
disease modifying factor that might be targeted in other conditions characterized by salt 
accumulation like chronic kidney disease and hypertension. 
 
Sources of funding 
Financial support from the Research Council of Norway (Project #262079) and from The 






Conflicts of interest/Disclosures 
None
References 
1. A global brief on hypertension; silent killer, global public health crisis. World 
Health Day 2013. Geneva: World Helath Oraganization Pres; 2013. 
2. Hay J. A British Medical Association Lecture on THE SIGNIFICANCE OF A RAISED 
BLOOD PRESSURE. Br Med J. 1931;2(3679):43-7. 
3. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood 
pressure lowering on cardiovascular and renal outcomes: updated systematic review 
and meta-analysis. Lancet. 2016;387(10017):435-43. 
4. Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. 
Circulation. 2000;101(3):329-35. 
5. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of 
lower sodium intake on health: systematic review and meta-analyses. BMJ. 
2013;346:f1326. 
6. Hall JE. Textbook of medical physiology. Thirteenth ed: Elsevier; 2016. 
7. Guyton AC, Coleman TG, Cowley AV, Jr., Scheel KW, Manning RD, Jr., Norman RA, 
Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term 
regulation and in hypertension. Am J Med. 1972;52(5):584-94. 
8. Wiig H, Luft FC, Titze JM. The interstitium conducts extrarenal storage of sodium 
and represents a third compartment essential for extracellular volume and blood 
pressure homeostasis. Acta Physiol (Oxf). 2018;222(3). 
9. Titze J, Lang R, Ilies C, Schwind KH, Kirsch KA, Dietsch P, et al. Osmotically 
inactive skin Na+ storage in rats. Am J Physiol Renal Physiol. 2003;285(6):F1108-17. 
10. Linz P, Santoro D, Renz W, Rieger J, Ruehle A, Ruff J, et al. Skin sodium measured 
with (2)(3)Na MRI at 7.0 T. NMR Biomed. 2015;28(1):54-62. 
11. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, et al. 
Macrophages regulate salt-dependent volume and blood pressure by a vascular 
endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009;15(5):545-
52. 
12. Machnik A, Dahlmann A, Kopp C, Goss J, Wagner H, van Rooijen N, et al. 
Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive 
enhancer binding protein/vascular endothelial growth factor C expression and induces 
salt-sensitive hypertension in rats. Hypertension. 2010;55(3):755-61. 
13. Wiig H, Schroder A, Neuhofer W, Jantsch J, Kopp C, Karlsen TV, et al. Immune cells 
control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest. 
2013;123(7):2803-15. 
14. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cifkova R, Dominiczak AF, et al. 
Hypertension. Nat Rev Dis Primers. 2018;4:18014. 
15. Coffman TM. Under pressure: the search for the essential mechanisms of 
hypertension. Nat Med. 2011;17(11):1402-9. 
16. Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: 
Physiological relevance and therapeutic implications in cardiovascular, hypertensive 
and kidney diseases. Pharmacol Res. 2017;125(Pt A):21-38. 
17. Joyner MJ, Charkoudian N, Wallin BG. Sympathetic nervous system and blood 
pressure in humans: individualized patterns of regulation and their implications. 
Hypertension. 2010;56(1):10-6. 
18. Miller AJ, Arnold AC. The renin-angiotensin system in cardiovascular autonomic 





19. Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: 
genomics and pharmacology. Trends Pharmacol Sci. 2002;23(4):177-83. 
20. Mirabito Colafella KM, Bovee DM, Danser AHJ. The renin angiotensin aldosterone 
system and its therapeutic targets. Exp Eye Res. 2019. 
21. Cannavo A, Bencivenga L, Liccardo D, Elia A, Marzano F, Gambino G, et al. 
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and 
Pathophysiology. Oxid Med Cell Longev. 2018;2018:1204598. 
22. de Leeuw PW, Bisognano JD, Bakris GL, Nadim MK, Haller H, Kroon AA, et al. 
Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results 
of the 6-Year Open Follow-Up. Hypertension. 2017;69(5):836-43. 
23. Vanhoutte PM, Mombouli JV. Vascular endothelium: vasoactive mediators. Prog 
Cardiovasc Dis. 1996;39(3):229-38. 
24. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on 
peripheral arteriolar tone in man. Lancet. 1989;2(8670):997-1000. 
25. Pittner J, Wolgast M, Casellas D, Persson AE. Increased shear stress-released NO 
and decreased endothelial calcium in rat isolated perfused juxtamedullary nephrons. 
Kidney Int. 2005;67(1):227-36. 
26. Ali A, Abu Zar M, Kamal A, Faquih AE, Bhan C, Iftikhar W, et al. American Heart 
Association High Blood Pressure Protocol 2017: A Literature Review. Cureus. 
2018;10(8):e3230. 
27. Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, 
and how to screen? Eur Heart J. 2014;35(19):1245-54. 
28. Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, et al. 
Systematic review: comparative effectiveness of angiotensin-converting enzyme 
inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann 
Intern Med. 2008;148(1):16-29. 
29. Dahl LK, Heine M, Thompson K. Genetic influence of the kidneys on blood 
pressure. Evidence from chronic renal homografts in rats with opposite predispositions 
to hypertension. Circ Res. 1974;34(1):94-101. 
30. Esler M. The 2009 Carl Ludwig Lecture: Pathophysiology of the human 
sympathetic nervous system in cardiovascular diseases: the transition from mechanisms 
to medical management. J Appl Physiol (1985). 2010;108(2):227-37. 
31. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, 
proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev. 
1979;59(4):919-57. 
32. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DA. Relationship between 
central sympathetic activity and stages of human hypertension. Am J Hypertens. 
2004;17(3):217-22. 
33. Goldstein DS. Plasma catecholamines and essential hypertension. An analytical 
review. Hypertension. 1983;5(1):86-99. 
34. Konukoglu D, Uzun H. Endothelial Dysfunction and Hypertension. Adv Exp Med 
Biol. 2017;956:511-40. 
35. Dharmashankar K, Widlansky ME. Vascular endothelial function and 
hypertension: insights and directions. Curr Hypertens Rep. 2010;12(6):448-55. 
36. Shiekh GA, Ayub T, Khan SN, Dar R, Andrabi KI. Reduced nitrate level in 
individuals with hypertension and diabetes. J Cardiovasc Dis Res. 2011;2(3):172-6. 
37. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived 
nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with 




38. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural 
and functional features of central nervous system lymphatic vessels. Nature. 
2015;523(7560):337-41. 
39. Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, et al. A dural 
lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp 
Med. 2015;212(7):991-9. 
40. Aspelund A, Tammela T, Antila S, Nurmi H, Leppanen VM, Zarkada G, et al. The 
Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel. J Clin Invest. 
2014;124(9):3975-86. 
41. Makinen T, Alitalo K. Molecular mechanisms of lymphangiogenesis. Cold Spring 
Harb Symp Quant Biol. 2002;67:189-96. 
42. Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev. 
2001;50(1-2):3-20. 
43. Hirakawa S, Detmar M, Karaman S. Lymphatics in nanophysiology. Adv Drug 
Deliv Rev. 2014;74:12-8. 
44. Vittet D. Lymphatic collecting vessel maturation and valve morphogenesis. 
Microvasc Res. 2014;96:31-7. 
45. Scallan JP, Zawieja SD, Castorena-Gonzalez JA, Davis MJ. Lymphatic pumping: 
mechanics, mechanisms and malfunction. J Physiol. 2016;594(20):5749-68. 
46. Breslin JW, Yang Y, Scallan JP, Sweat RS, Adderley SP, Murfee WL. Lymphatic 
Vessel Network Structure and Physiology. Compr Physiol. 2018;9(1):207-99. 
47. Wiig H, Swartz MA. Interstitial fluid and lymph formation and transport: 
physiological regulation and roles in inflammation and cancer. Physiol Rev. 
2012;92(3):1005-60. 
48. Jacob M, Chappell D. Reappraising Starling: the physiology of the 
microcirculation. Curr Opin Crit Care. 2013;19(4):282-9. 
49. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling 
principle. Cardiovasc Res. 2010;87(2):198-210. 
50. Clement CC, Aphkhazava D, Nieves E, Callaway M, Olszewski W, Rotzschke O, et 
al. Protein expression profiles of human lymph and plasma mapped by 2D-DIGE and 1D 
SDS-PAGE coupled with nanoLC-ESI-MS/MS bottom-up proteomics. J Proteomics. 
2013;78:172-87. 
51. Leak LV, Liotta LA, Krutzsch H, Jones M, Fusaro VA, Ross SJ, et al. Proteomic 
analysis of lymph. Proteomics. 2004;4(3):753-65. 
52. Dzieciatkowska M, D'Alessandro A, Moore EE, Wohlauer M, Banerjee A, Silliman 
CC, et al. Lymph is not a plasma ultrafiltrate: a proteomic analysis of injured patients. 
Shock. 2014;42(6):485-98. 
53. Clement CC, Santambrogio L. The lymph self-antigen repertoire. Front Immunol. 
2013;4:424. 
54. Santambrogio L, Rammensee HG. Contribution of the plasma and lymph 
Degradome and Peptidome to the MHC Ligandome. Immunogenetics. 2019;71(3):203-
16. 
55. Haljamae H, Linde A, Amundson B. Comparative analyses of capsular fluid and 
interstitial fluid. Am J Physiol. 1974;227(5):1199-205. 
56. Szabo G, Magyar Z. Electrolyte concentrations in subcutaneous tissue fluid and 
lymph. Lymphology. 1982;15(4):174-7. 
57. Aukland K, Reed RK. Interstitial-lymphatic mechanisms in the control of 




58. Guyton AC, Taylor AE, Brace RA. A synthesis of interstitial fluid regulation and 
lymph formation. Fed Proc. 1976;35(8):1881-5. 
59. von der Weid PY. Review article: lymphatic vessel pumping and inflammation--
the role of spontaneous constrictions and underlying electrical pacemaker potentials. 
Aliment Pharmacol Ther. 2001;15(8):1115-29. 
60. Benoit JN, Zawieja DC, Goodman AH, Granger HJ. Characterization of intact 
mesenteric lymphatic pump and its responsiveness to acute edemagenic stress. Am J 
Physiol. 1989;257(6 Pt 2):H2059-69. 
61. Olszewski WL, Engeset A. Intrinsic contractility of prenodal lymph vessels and 
lymph flow in human leg. Am J Physiol. 1980;239(6):H775-83. 
62. Van Helden DF. Pacemaker potentials in lymphatic smooth muscle of the guinea-
pig mesentery. J Physiol. 1993;471:465-79. 
63. von der Weid PY, Zawieja DC. Lymphatic smooth muscle: the motor unit of lymph 
drainage. Int J Biochem Cell Biol. 2004;36(7):1147-53. 
64. Solari E, Marcozzi C, Negrini D, Moriondo A. Fluid Osmolarity Acutely and 
Differentially Modulates Lymphatic Vessels Intrinsic Contractions and Lymph Flow. 
Front Physiol. 2018;9:871. 
65. Sabin FR. The Method of Growth of the Lymphatic System. Science. 
1916;44(1127):145-58. 
66. Schneider M, Othman-Hassan K, Christ B, Wilting J. Lymphangioblasts in the 
avian wing bud. Dev Dyn. 1999;216(4-5):311-9. 
67. Martinez-Corral I, Ulvmar MH, Stanczuk L, Tatin F, Kizhatil K, John SW, et al. 
Nonvenous origin of dermal lymphatic vasculature. Circ Res. 2015;116(10):1649-54. 
68. Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dube KN, et al. Cardiac 
lymphatics are heterogeneous in origin and respond to injury. Nature. 
2015;522(7554):62-7. 
69. Kim H, Kataru RP, Koh GY. Regulation and implications of inflammatory 
lymphangiogenesis. Trends Immunol. 2012;33(7):350-6. 
70. Karaman S, Leppanen VM, Alitalo K. Vascular endothelial growth factor signaling 
in development and disease. Development. 2018;145(14). 
71. Shibuya M. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) 
Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. 
Genes Cancer. 2011;2(12):1097-105. 
72. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, et al. Vascular 
endothelial growth factor C is required for sprouting of the first lymphatic vessels from 
embryonic veins. Nat Immunol. 2004;5(1):74-80. 
73. Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF 
receptor system and its role under physiological and pathological conditions. Clin Sci 
(Lond). 2005;109(3):227-41. 
74. Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, et al. 
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice 
expressing soluble VEGF receptor-3. Nat Med. 2001;7(2):199-205. 
75. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia 
of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276(5317):1423-5. 
76. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et 
al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic 




77. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, et al. Tumor-
associated macrophages express lymphatic endothelial growth factors and are related to 
peritumoral lymphangiogenesis. Am J Pathol. 2002;161(3):947-56. 
78. Ran S, Montgomery KE. Macrophage-mediated lymphangiogenesis: the emerging 
role of macrophages as lymphatic endothelial progenitors. Cancers (Basel). 
2012;4(3):618-57. 
79. Dabrowska AK, Spano F, Derler S, Adlhart C, Spencer ND, Rossi RM. The 
relationship between skin function, barrier properties, and body-dependent factors. 
Skin Res Technol. 2018;24(2):165-74. 
80. Nguyen AV, Soulika AM. The Dynamics of the Skin's Immune System. Int J Mol Sci. 
2019;20(8). 
81. Agarwal S, Krishnamurthy K. Histology, Skin.  StatPearls. Treasure Island 
(FL)2019. 
82. Richmond JM, Harris JE. Immunology and skin in health and disease. Cold Spring 
Harb Perspect Med. 2014;4(12):a015339. 
83. Has C, Nystrom A. Epidermal Basement Membrane in Health and Disease. Curr 
Top Membr. 2015;76:117-70. 
84. Brown TM, Krishnamurthy K. Histology, Dermis.  StatPearls. Treasure Island 
(FL)2019. 
85. Arda O, Goksugur N, Tuzun Y. Basic histological structure and functions of facial 
skin. Clin Dermatol. 2014;32(1):3-13. 
86. Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix 
structure. Adv Drug Deliv Rev. 2016;97:4-27. 
87. Wiig H, Keskin D, Kalluri R. Interaction between the extracellular matrix and 
lymphatics: consequences for lymphangiogenesis and lymphatic function. Matrix Biol. 
2010;29(8):645-56. 
88. Domene C, Jorgensen C, Abbasi SW. A perspective on structural and 
computational work on collagen. Phys Chem Chem Phys. 2016;18(36):24802-11. 
89. Arora H, Falto-Aizpurua L, Cortes-Fernandez A, Choudhary S, Romanelli P. 
Connective Tissue Nevi: A Review of the Literature. Am J Dermatopathol. 
2017;39(5):325-41. 
90. Frances C, Robert L. Elastin and elastic fibers in normal and pathologic skin. Int J 
Dermatol. 1984;23(3):166-79. 
91. Lee DH, Oh JH, Chung JH. Glycosaminoglycan and proteoglycan in skin aging. J 
Dermatol Sci. 2016;83(3):174-81. 
92. Oh JH, Kim YK, Jung JY, Shin JE, Kim KH, Cho KH, et al. Intrinsic aging- and 
photoaging-dependent level changes of glycosaminoglycans and their correlation with 
water content in human skin. J Dermatol Sci. 2011;62(3):192-201. 
93. Anderegg U, Simon JC, Averbeck M. More than just a filler - the role of hyaluronan 
for skin homeostasis. Exp Dermatol. 2014;23(5):295-303. 
94. Karsdal MA, Nielsen MJ, Sand JM, Henriksen K, Genovese F, Bay-Jensen AC, et al. 
Extracellular matrix remodeling: the common denominator in connective tissue 
diseases. Possibilities for evaluation and current understanding of the matrix as more 
than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol. 
2013;11(2):70-92. 
95. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of 




96. Jablonska-Trypuc A, Matejczyk M, Rosochacki S. Matrix metalloproteinases 
(MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a 
target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177-83. 
97. Theocharis AD, Manou D, Karamanos NK. The extracellular matrix as a 
multitasking player in disease. FEBS J. 2019. 
98. Karamanos NK, Theocharis AD, Neill T, Iozzo RV. Matrix modeling and 
remodeling: A biological interplay regulating tissue homeostasis and diseases. Matrix 
Biol. 2019;75-76:1-11. 
99. Muller DN, Wilck N, Haase S, Kleinewietfeld M, Linker RA. Sodium in the 
microenvironment regulates immune responses and tissue homeostasis. Nat Rev 
Immunol. 2019;19(4):243-54. 
100. Sattler S. The Role of the Immune System Beyond the Fight Against Infection. Adv 
Exp Med Biol. 2017;1003:3-14. 
101. Mirza R, DiPietro LA, Koh TJ. Selective and specific macrophage ablation is 
detrimental to wound healing in mice. Am J Pathol. 2009;175(6):2454-62. 
102. Sattler S, Rosenthal N. The neonate versus adult mammalian immune system in 
cardiac repair and regeneration. Biochim Biophys Acta. 2016;1863(7 Pt B):1813-21. 
103. Lin SL, Li B, Rao S, Yeo EJ, Hudson TE, Nowlin BT, et al. Macrophage Wnt7b is 
critical for kidney repair and regeneration. Proc Natl Acad Sci U S A. 2010;107(9):4194-
9. 
104. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, et al. WNT7b mediates 
macrophage-induced programmed cell death in patterning of the vasculature. Nature. 
2005;437(7057):417-21. 
105. Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev 
Immunol. 2014;32:609-34. 
106. Abboud FM, Singh MV. Autonomic regulation of the immune system in 
cardiovascular diseases. Adv Physiol Educ. 2017;41(4):578-93. 
107. Galloway DA, Phillips AEM, Owen DRJ, Moore CS. Phagocytosis in the Brain: 
Homeostasis and Disease. Front Immunol. 2019;10:790. 
108. Clayton K, Vallejo AF, Davies J, Sirvent S, Polak ME. Langerhans Cells-
Programmed by the Epidermis. Front Immunol. 2017;8:1676. 
109. Platt AM, Randolph GJ. Dendritic cell migration through the lymphatic 
vasculature to lymph nodes. Adv Immunol. 2013;120:51-68. 
110. Hettinger J, Richards DM, Hansson J, Barra MM, Joschko AC, Krijgsveld J, et al. 
Origin of monocytes and macrophages in a committed progenitor. Nat Immunol. 
2013;14(8):821-30. 
111. Yanez DA, Lacher RK, Vidyarthi A, Colegio OR. The role of macrophages in skin 
homeostasis. Pflugers Arch. 2017;469(3-4):455-63. 
112. Minutti CM, Knipper JA, Allen JE, Zaiss DM. Tissue-specific contribution of 
macrophages to wound healing. Semin Cell Dev Biol. 2017;61:3-11. 
113. Willenborg S, Lucas T, van Loo G, Knipper JA, Krieg T, Haase I, et al. CCR2 recruits 
an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. 
Blood. 2012;120(3):613-25. 
114. Willard-Mack CL. Normal structure, function, and histology of lymph nodes. 
Toxicol Pathol. 2006;34(5):409-24. 
115. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev 
Immunol. 2003;3(11):867-78. 
116. Worbs T, Hammerschmidt SI, Forster R. Dendritic cell migration in health and 




117. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ 
Res. 2003;92(7):801-8. 
118. Weber M, Hauschild R, Schwarz J, Moussion C, de Vries I, Legler DF, et al. 
Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science. 
2013;339(6117):328-32. 
119. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of 
a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J 
Exp Med. 2002;196(8):1079-90. 
120. Miteva DO, Rutkowski JM, Dixon JB, Kilarski W, Shields JD, Swartz MA. 
Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. 
Circ Res. 2010;106(5):920-31. 
121. Martin-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, Lanzavecchia 
A, et al. Regulation of dendritic cell migration to the draining lymph node: Impact on T 
lymphocyte traffic and priming. Journal of Experimental Medicine. 2003;198(4):615-21. 
122. Thomas SN, Rutkowski JM, Pasquier M, Kuan EL, Alitalo K, Randolph GJ, et al. 
Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal 
lymphatic drainage. J Immunol. 2012;189(5):2181-90. 
123. Drummond GR, Vinh A, Guzik TJ, Sobey CG. Immune mechanisms of hypertension. 
Nat Rev Immunol. 2019. 
124. Okuda T, Grollman A. Passive transfer of autoimmune induced hypertension in 
the rat by lymph node cells. Tex Rep Biol Med. 1967;25(2):257-64. 
125. Olsen F. Transfer of arterial hypertension by splenic cells from DOCA-salt 
hypertensive and renal hypertensive rats to normotensive recipients. Acta Pathol 
Microbiol Scand C. 1980;88(1):1-5. 
126. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, et al. Role of the 
T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J 
Exp Med. 2007;204(10):2449-60. 
127. Pollow DP, Uhrlaub J, Romero-Aleshire M, Sandberg K, Nikolich-Zugich J, Brooks 
HL, et al. Sex differences in T-lymphocyte tissue infiltration and development of 
angiotensin II hypertension. Hypertension. 2014;64(2):384-90. 
128. Lob HE, Marvar PJ, Guzik TJ, Sharma S, McCann LA, Weyand C, et al. Induction of 
hypertension and peripheral inflammation by reduction of extracellular superoxide 
dismutase in the central nervous system. Hypertension. 2010;55(2):277-83, 6p 
following 83. 
129. Trott DW, Harrison DG. The immune system in hypertension. Adv Physiol Educ. 
2014;38(1):20-4. 
130. Saleh MA, McMaster WG, Wu J, Norlander AE, Funt SA, Thabet SR, et al. 
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ 
inflammation. J Clin Invest. 2015;125(3):1189-202. 
131. Ren J, Crowley SD. Role of T-cell activation in salt-sensitive hypertension. Am J 
Physiol Heart Circ Physiol. 2019;316(6):H1345-H53. 
132. Ugur M, Mueller SN. T cell and dendritic cell interactions in lymphoid organs: 
More than just being in the right place at the right time. Immunol Rev. 2019;289(1):115-
28. 
133. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, et al. Inhibition and 
genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental 




134. Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, et al. DC isoketal-
modified proteins activate T cells and promote hypertension. J Clin Invest. 
2014;124(10):4642-56. 
135. Salomon RG, Bi W. Isolevuglandin adducts in disease. Antioxid Redox Signal. 
2015;22(18):1703-18. 
136. Pons H, Ferrebuz A, Quiroz Y, Romero-Vasquez F, Parra G, Johnson RJ, et al. 
Immune reactivity to heat shock protein 70 expressed in the kidney is cause of salt-
sensitive hypertension. Am J Physiol Renal Physiol. 2013;304(3):F289-99. 
137. Tobias A, Mohiuddin SS. Physiology, Water Balance.  StatPearls. Treasure Island 
(FL)2019. 
138. Shrimanker I, Bhattarai S. Electrolytes.  StatPearls. Treasure Island (FL)2019. 
139. Chen JS, Al Khalili Y. Physiology, Osmoregulation and Excretion.  StatPearls. 
Treasure Island (FL)2019. 
140. Ogobuiro I, Tuma F. Physiology, Renal.  StatPearls. Treasure Island (FL)2019. 
141. Palmer LG, Schnermann J. Integrated control of Na transport along the nephron. 
Clin J Am Soc Nephrol. 2015;10(4):676-87. 
142. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. 
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: 
observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 
2007;334(7599):885-8. 
143. He FJ, MacGregor GA. A comprehensive review on salt and health and current 
experience of worldwide salt reduction programmes. J Hum Hypertens. 2009;23(6):363-
84. 
144. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on 
blood pressure of reduced dietary sodium and the Dietary Approaches to Stop 
Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 
2001;344(1):3-10. 
145. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and 
characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 
1986;8(6 Pt 2):II127-34. 
146. Guyton AC. Blood pressure control--special role of the kidneys and body fluids. 
Science. 1991;252(5014):1813-6. 
147. Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride 
consumption may not induce body fluid retention in humans. Am J Physiol Renal 
Physiol. 2000;278(4):F585-95. 
148. Titze J, Maillet A, Lang R, Gunga HC, Johannes B, Gauquelin-Koch G, et al. Long-
term sodium balance in humans in a terrestrial space station simulation study. Am J 
Kidney Dis. 2002;40(3):508-16. 
149. Rakova N, Juttner K, Dahlmann A, Schroder A, Linz P, Kopp C, et al. Long-term 
space flight simulation reveals infradian rhythmicity in human Na(+) balance. Cell 
Metab. 2013;17(1):125-31. 
150. Titze J. Water-free sodium accumulation. Semin Dial. 2009;22(3):253-5. 
151. Nikpey E, Karlsen TV, Rakova N, Titze JM, Tenstad O, Wiig H. High-Salt Diet 
Causes Osmotic Gradients and Hyperosmolality in Skin Without Affecting Interstitial 
Fluid and Lymph. Hypertension. 2017;69(4):660-8. 
152. Hofmeister LH, Perisic S, Titze J. Tissue sodium storage: evidence for kidney-like 




153. Kopp C, Linz P, Dahlmann A, Hammon M, Jantsch J, Muller DN, et al. 23Na 
magnetic resonance imaging-determined tissue sodium in healthy subjects and 
hypertensive patients. Hypertension. 2013;61(3):635-40. 
154. Muller S, Quast T, Schroder A, Hucke S, Klotz L, Jantsch J, et al. Salt-dependent 
chemotaxis of macrophages. PLoS One. 2013;8(9):e73439. 
155. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, et al. A 
model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A. 
2001;98(22):12677-82. 
156. Makinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC, et al. Isolated 
lymphatic endothelial cells transduce growth, survival and migratory signals via the 
VEGF-C/D receptor VEGFR-3. EMBO J. 2001;20(17):4762-73. 
157. Niemeyer JE. Telemetry for small animal physiology. Lab Anim (NY). 
2016;45(7):255-7. 
158. Karlsen TV, McCormack E, Mujic M, Tenstad O, Wiig H. Minimally invasive 
quantification of lymph flow in mice and rats by imaging depot clearance of near-
infrared albumin. Am J Physiol Heart Circ Physiol. 2012;302(2):H391-401. 
159. Janssen PM, Biesiadecki BJ, Ziolo MT, Davis JP. The Need for Speed: Mice, Men, 
and Myocardial Kinetic Reserve. Circ Res. 2016;119(3):418-21. 
160. Reckelhoff JF, Alexander BT. Reproducibility in animal models of hypertension: a 
difficult problem. Biol Sex Differ. 2018;9(1):53. 
161. Lerman LO, Kurtz TW, Touyz RM, Ellison DH, Chade AR, Crowley SD, et al. Animal 
Models of Hypertension: A Scientific Statement From the American Heart Association. 
Hypertension. 2019;73(6):e87-e120. 
162. Hartner A, Cordasic N, Klanke B, Veelken R, Hilgers KF. Strain differences in the 
development of hypertension and glomerular lesions induced by deoxycorticosterone 
acetate salt in mice. Nephrol Dial Transplant. 2003;18(10):1999-2004. 
163. Drenjancevic-Peric I, Jelakovic B, Lombard JH, Kunert MP, Kibel A, Gros M. High-
salt diet and hypertension: focus on the renin-angiotensin system. Kidney Blood Press 
Res. 2011;34(1):1-11. 
164. Kandlikar SS, Fink GD. Splanchnic sympathetic nerves in the development of mild 
DOCA-salt hypertension. Am J Physiol Heart Circ Physiol. 2011;301(5):H1965-73. 
165. Lin HY, Lee YT, Chan YW, Tse G. Animal models for the study of primary and 
secondary hypertension in humans. Biomed Rep. 2016;5(6):653-9. 
166. Basting T, Lazartigues E. DOCA-Salt Hypertension: an Update. Curr Hypertens 
Rep. 2017;19(4):32. 
167. Martus W, Kim D, Garvin JL, Beierwaltes WH. Commercial rodent diets contain 
more sodium than rats need. Am J Physiol Renal Physiol. 2005;288(2):F428-31. 
168. Zhao X, Ho D, Gao S, Hong C, Vatner DE, Vatner SF. Arterial Pressure Monitoring 
in Mice. Curr Protoc Mouse Biol. 2011;1:105-22. 
169. Carlson SH, Wyss JM. Long-term telemetric recording of arterial pressure and 
heart rate in mice fed basal and high NaCl diets. Hypertension. 2000;35(2):E1-5. 
170. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE, Subcommittee of P, et al. 
Recommendations for blood pressure measurement in humans and experimental 
animals. Part 2: Blood pressure measurement in experimental animals: a statement for 
professionals from the subcommittee of professional and public education of the 





171. Wilde E, Aubdool AA, Thakore P, Baldissera L, Jr., Alawi KM, Keeble J, et al. Tail-
Cuff Technique and Its Influence on Central Blood Pressure in the Mouse. J Am Heart 
Assoc. 2017;6(6). 
172. Salay LD, Ishiko N, Huberman AD. A midline thalamic circuit determines 
reactions to visual threat. Nature. 2018;557(7704):183-9. 
173. Taylor CR, Levenson RM. Quantification of immunohistochemistry--issues 
concerning methods, utility and semiquantitative assessment II. Histopathology. 
2006;49(4):411-24. 
174. Adan A, Alizada G, Kiraz Y, Baran Y, Nalbant A. Flow cytometry: basic principles 
and applications. Crit Rev Biotechnol. 2017;37(2):163-76. 
175. Proulx ST, Ma Q, Andina D, Leroux JC, Detmar M. Quantitative measurement of 
lymphatic function in mice by noninvasive near-infrared imaging of a peripheral vein. 
JCI Insight. 2017;2(1):e90861. 
176. Wiig H, Reed RK, Aukland K. Micropuncture measurement of interstitial fluid 
pressure in rat subcutis and skeletal muscle: comparison to wick-in-needle technique. 
Microvasc Res. 1981;21(3):308-19. 
177. Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, Antsiferova 
M, et al. An important role of lymphatic vessel activation in limiting acute inflammation. 
Blood. 2011;117(17):4667-78. 
178. Huggenberger R, Ullmann S, Proulx ST, Pytowski B, Alitalo K, Detmar M. 
Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp 
Med. 2010;207(10):2255-69. 
179. Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, et al. Critical role of 
CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, 
and inflammation resolution. Blood. 2009;113(22):5650-9. 
180. Lachance PA, Hazen A, Sevick-Muraca EM. Lymphatic vascular response to acute 
inflammation. PLoS One. 2013;8(9):e76078. 
181. Chakraborty S, Davis MJ, Muthuchamy M. Emerging trends in the 
pathophysiology of lymphatic contractile function. Semin Cell Dev Biol. 2015;38:55-66. 
182. Christiansen AJ, Dieterich LC, Ohs I, Bachmann SB, Bianchi R, Proulx ST, et al. 
Lymphatic endothelial cells attenuate inflammation via suppression of dendritic cell 
maturation. Oncotarget. 2016;7(26):39421-35. 
183. Kitada K, Daub S, Zhang Y, Klein JD, Nakano D, Pedchenko T, et al. High salt intake 
reprioritizes osmolyte and energy metabolism for body fluid conservation. J Clin Invest. 
2017;127(5):1944-59. 
184. Van Beusecum JP, Barbaro NR, McDowell Z, Aden LA, Xiao L, Pandey AK, et al. 
High Salt Activates CD11c(+) Antigen-Presenting Cells via SGK (Serum Glucocorticoid 
Kinase) 1 to Promote Renal Inflammation and Salt-Sensitive Hypertension. 
Hypertension. 2019;74(3):555-63. 
185. Chachaj A, Pula B, Chabowski M, Grzegrzolka J, Szahidewicz-Krupska E, 
Karczewski M, et al. Role of the Lymphatic System in the Pathogenesis of Hypertension 
in Humans. Lymphat Res Biol. 2018;16(2):140-6. 
186. Lankhorst S, Severs D, Marko L, Rakova N, Titze J, Muller DN, et al. Salt Sensitivity 
of Angiogenesis Inhibition-Induced Blood Pressure Rise: Role of Interstitial Sodium 
Accumulation? Hypertension. 2017;69(5):919-26. 
187. Titze J, Bauer K, Schafflhuber M, Dietsch P, Lang R, Schwind KH, et al. Internal 





188. Ziomber A, Machnik A, Dahlmann A, Dietsch P, Beck FX, Wagner H, et al. Sodium-, 
potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte 
homeostasis in deoxycorticosterone acetate-treated rats. Am J Physiol Renal Physiol. 
2008;295(6):F1752-63. 
189. Fuller W, Tulloch LB, Shattock MJ, Calaghan SC, Howie J, Wypijewski KJ. 
Regulation of the cardiac sodium pump. Cell Mol Life Sci. 2013;70(8):1357-80. 
190. Doyle D, Smith R, Krozowski ZS, Funder JW. Mineralocorticoid specificity of renal 
type I receptors: binding and metabolism of corticosterone. J Steroid Biochem. 
1989;33(2):165-70. 
191. Tesch GH, Young MJ. Mineralocorticoid Receptor Signaling as a Therapeutic 
Target for Renal and Cardiac Fibrosis. Front Pharmacol. 2017;8:313. 
192. Chadwick JA, Hauck JS, Gomez-Sanchez CE, Gomez-Sanchez EP, Rafael-Fortney JA. 
Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and 
antagonists on normal human skeletal muscle. Physiol Genomics. 2017;49(6):277-86. 
193. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in 
subjects with resistant hypertension. Am J Hypertens. 2003;16(11 Pt 1):925-30. 
194. Shibata H, Itoh H. Mineralocorticoid receptor-associated hypertension and its 
organ damage: clinical relevance for resistant hypertension. Am J Hypertens. 
2012;25(5):514-23. 
195. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, et al. The effect of 
weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J 
Med. 1989;321(9):580-5. 
196. Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17(11):1371-80. 
197. Aspelund A, Robciuc MR, Karaman S, Makinen T, Alitalo K. Lymphatic System in 
Cardiovascular Medicine. Circ Res. 2016;118(3):515-30. 
198. Aebischer D, Iolyeva M, Halin C. The inflammatory response of lymphatic 
endothelium. Angiogenesis. 2014;17(2):383-93. 
199. Kim H, Kataru RP, Koh GY. Inflammation-associated lymphangiogenesis: a 
double-edged sword? J Clin Invest. 2014;124(3):936-42. 
200. Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, Antsiferova 
M, et al. An important role of lymphatic vessel activation in limiting acute inflammation. 
Blood. 2011;117(17):4667-78. 
201. Kajiya K, Sawane M, Huggenberger R, Detmar M. Activation of the VEGFR-3 
pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by 
promoting lymphangiogenesis. J Invest Dermatol. 2009;129(5):1292-8. 
202. Liao S, Cheng G, Conner DA, Huang Y, Kucherlapati RS, Munn LL, et al. Impaired 
lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci U S A. 
2011;108(46):18784-9. 
203. Randolph GJ, Ivanov S, Zinselmeyer BH, Scallan JP. The Lymphatic System: 
Integral Roles in Immunity. Annu Rev Immunol. 2016. 
204. Guyton AC, Scheel K, Murphree D. Interstitial fluid pressure. 3. Its effect on 
resistance to tissue fluid mobility. Circ Res. 1966;19(2):412-9. 
205. Bates DO, Lodwick D, Williams B. Vascular endothelial growth factor and 
microvascular permeability. Microcirculation. 1999;6(2):83-96. 
206. Modi S, Stanton AW, Mortimer PS, Levick JR. Clinical assessment of human lymph 
flow using removal rate constants of interstitial macromolecules: a critical review of 
lymphoscintigraphy. Lymphat Res Biol. 2007;5(3):183-202. 
207. Aldrich MB, Sevick-Muraca EM. Cytokines are systemic effectors of lymphatic 




208. Papadakou P, Bletsa A, Yassin MA, Karlsen TV, Wiig H, Berggreen E. Role of 
Hyperplasia of Gingival Lymphatics in Periodontal Inflammation. J Dent Res. 
2017;96(4):467-76. 
209. Zhou Q, Guo R, Wood R, Boyce BF, Liang Q, Wang YJ, et al. Vascular endothelial 
growth factor C attenuates joint damage in chronic inflammatory arthritis by 
accelerating local lymphatic drainage in mice. Arthritis Rheum. 2011;63(8):2318-28. 
210. Lahteenvuo M, Honkonen K, Tervala T, Tammela T, Suominen E, Lahteenvuo J, et 
al. Growth factor therapy and autologous lymph node transfer in lymphedema. 
Circulation. 2011;123(6):613-20. 
211. Guyton AC, Coleman TG, Cowley AW, Manning RD, Norman RA, Ferguson JD. A 
systems analysis approach to understanding long-range arterial blood pressure control 
and hypertension. Circ Res. 1974;35:159 - 76. 
212. Palacios C, Wigertz K, Martin BR, Jackman L, Pratt JH, Peacock M, et al. Sodium 
retention in black and white female adolescents in response to salt intake. J Clin 
Endocrinol Metab. 2004;89(4):1858-63. 
213. Schafflhuber M, Volpi N, Dahlmann A, Hilgers KF, Maccari F, Dietsch P, et al. 
Mobilization of osmotically inactive Na+ by growth and by dietary salt restriction in rats. 
Am J Physiol Renal Physiol. 2007;292(5):F1490-500. 
214. Titze J, Krause H, Hecht H, Dietsch P, Rittweger J, Lang R, et al. Reduced 
osmotically inactive Na storage capacity and hypertension in the Dahl model. Am J 
Physiol Renal Physiol. 2002;283(1):F134-41. 
215. Titze J, Luft FC, Bauer K, Dietsch P, Lang R, Veelken R, et al. Extrarenal Na+ 
balance, volume, and blood pressure homeostasis in intact and ovariectomized 
deoxycorticosterone-acetate salt rats. Hypertension. 2006;47(6):1101-7. 
216. Wiig H, Tenstad O, Bert JL. Effect of hydration on interstitial distribution of 
charged albumin in rat dermis in vitro. J Physiol. 2005;569(Pt 2):631-41. 
217. Karlsen TV, Reikvam T, Tofteberg A, Nikpey E, Skogstrand T, Wagner M, et al. 
Lymphangiogenesis Facilitates Initial Lymph Formation and Enhances the Dendritic Cell 
Mobilizing Chemokine CCL21 Without Affecting Migration. Arterioscler Thromb Vasc 
Biol. 2017;37(11):2128-35. 
218. Scallan JP, Davis MJ. Genetic removal of basal nitric oxide enhances contractile 
activity in isolated murine collecting lymphatic vessels. J Physiol. 2013;591(8):2139-56. 
219. Scallan JP, Wolpers JH, Davis MJ. Constriction of isolated collecting lymphatic 
vessels in response to acute increases in downstream pressure. J Physiol. 
2013;591(2):443-59. 
220. Gashev AA, Davis MJ, Zawieja DC. Inhibition of the active lymph pump by flow in 
rat mesenteric lymphatics and thoracic duct. J Physiol. 2002;540(Pt 3):1023-37. 
221. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 
2008;452(7187):580-9. 
222. Mumprecht V, Honer M, Vigl B, Proulx ST, Trachsel E, Kaspar M, et al. In vivo 
imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by 
immuno-positron emission tomography. Cancer Res. 2010;70(21):8842-51. 
223. Kwon S, Agollah GD, Chan W, Sevick-Muraca EM. Altered lymphatic function and 
architecture in salt-induced hypertension assessed by near-infrared fluorescence 
imaging. J Biomed Opt. 2012;17(8):080504-1. 
224. Zawieja SD, Castorena-Gonzalez JA, Scallan JP, Davis MJ. Differences in L-type 
Ca(2+) channel activity partially underlie the regional dichotomy in pumping behavior 





225. Breslin JW, Gaudreault N, Watson KD, Reynoso R, Yuan SY, Wu MH. Vascular 
endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-
dependent mechanism. Am J Physiol Heart Circ Physiol. 2007;293(1):H709-18. 
226. Dahlmann A, Dorfelt K, Eicher F, Linz P, Kopp C, Mossinger I, et al. Magnetic 
resonance-determined sodium removal from tissue stores in hemodialysis patients. 
Kidney Int. 2015;87(2):434-41. 
227. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, et al. Sodium 






 Increase in lymph flow during salt accumulation suggest that lymphatics may 
contribute in long term regulation of tissue fluid balance and blood pressure by 
contributing to fluid homeostasis in skin and muscle.  
 Recently it has been shown that considerable amounts of Na+ can be retained or 
removed from the body without commensurate water loss, and that the skin can 
serve as a major salt reservoir contributing in blood pressure regulation. 
 We identify lymph clearance as a potential disease modifying factor that might be 
targeted in conditions characterized by salt accumulation like chronic kidney 
disease and salt-sensitive hypertension.
Figures 
 
Figure 1. A. Individual values of mean arterial blood pressure measured with tail cuff 
plethysmography in awake rats after 14 days of either low salt diet (LSD), high salt diet 
(HSD) or DOCA-salt diet. B. Individual values of skin water content in LSD, HSD and 
DOCA-salt diet. C. Individual values of skin Na+ content relative to skin water in LSD, 
HSD and DOCA-salt diet. D. Individual values of skin Na+ content relative to dry weight in 
LSD, HSD and DOCA-salt diet. E. Representative ear skin sections showing LYVE-1+ 
lymphatic vessels in LSD, HSD and DOCA-salt fed rats. Scale bar = 50 µm. F.  LYVE-1+ 
lymphatic vessels were counted in 5-7 consecutive fields per section from 3 rats per 
group. Also shown mean ± SD. *P<0.05, ***P<0.001, ****P<0.0001 when compared to 













































































































Figure 2. A. Average Loge fraction of counts remaining in the intradermally injected 
depot of 3 µl macromolecular tracer (Alexa680-BSA) in hind paw of rats on LSD (n=19), 
HSD (n=20) and DOCA-salt diet (n=12). B. Individual rate constants (k) calculated as the 
slope of the monoexponential washout curves for each individual rat in (A) obtained by 
linear regression analysis. C. Individual values representing the fraction of counts 
remaining in the intradermal depot 22 hours after injection of 3 µl Alexa680-BSA in LSD, 
HSD and DOCA-salt diet. Also shown mean ± SD. *P<0.05, **P<0.01 (ANOVA followed by 



















































































Figure 3. A. HPLC chromatogram of unlabeled native HSA at an ultraviolet (UV) 
detection of 220 nm compared to elution of 124I-labeled HSA counted with a gamma 
counter. The UV-activity around 12 and 16 ml elution volume represent buffer. Of note, 
the free 124I is zero.  B. Representative image of a PET/CT scan showing the time-
dependent washout of an intramuscularly injected macromolecular tracer (3 µl 124I-
HSA) in thigh muscle. C. Average Loge fraction of counts remaining in the 
intramuscularly injected depot of 3 µl 124I-HSA with time in thigh muscle of rats on LSD 
(n=7) and HSD (n=6). D. Individual rate constants (k) calculated as the slope of the 
monoexponential washout curves for each individual rat in (B) obtained by linear 
regression analysis. E. Individual values representing the fraction of counts remaining in 
the intramuscular depot 22 hours after injection of 3 µl 124I-HSA in LSD and HSD. Also 


































































































Figure 4. Individual values for extravasation of the radioactive macromolecular tracer 
125I-HSA from the vasculature into paw skin (A) and thigh muscle (B) after 35 min in 
LSD, HSD and DOCA-salt diet rats. Five min extravasation of 131I-HSA was subtracted 
from these values to correct for any plasma 125I-HSA present in the excised tissue at 35 




































































Figure 5. A. Representative staining of MPS cells with CD68 in ear sections from rats fed 
LSD, HSD and DOCA-salt diet with or without clodronate liposome injection. Scale bar = 
50 µm. B. CD68+ MPS cells were counted in 4 consecutive fields per section from 4 rats 
per group.  C. Individual rate constants (k) from skin calculated as the slope of 
monoexponential washout curves obtained by linear regression analysis for each 
individual rat in a separate set of experiments where rats on LSD, HSD) and DOCA-salt 
diet received intraperitoneal liposomal clodronate. Injections (5 mg in 1 ml) every 4th 
day, started at day 0 of the respective diets, with the last injection at day 12. For 
comparison, the mean values ± SD of the rate constants calculated in Fig 2B are also 
shown, representing k-values from rats on LSD, HSD and DOCA-salt without clodronate 
injections. D. Individual values representing the fraction of counts remaining in the 
intradermal depot 22 hours after injection of 3 µl Alexa680-BSA in clodronate injected 
LSD, HSD and DOCA-salt diet rats. Mean values ± SD from fig 2C representing rats 
without clodronate injections are included for comparison. Also shown mean ± SD for 
clodronate injected rats. *P<0.05, ***P<0.001, ****P<0.0001 for comparisons within the 
respective diet groups (unpaired t-tests). †††† P<0.0001 for comparisons between diet 
groups (ANOVA followed by Dunnett’s multiple comparison test). 
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Figure 6. A. An image of a cannulated mouse inguinal afferent lymphatic vessel. B and C. 
Example recordings showing the pattern of spontaneous lymphatic contractions at each 
level of pressure (0.5 to 10 cmH2O) in 145 mmol Na+ Krebs solution (B) and 185 mmol 
Na+ Krebs solution (C). Each downward deflection represents a single contraction 
lasting 3-5 sec. Pin and Pout are the pressures set by the input and output cannulas, 
respectively, and were equal throughout the pressure step protocol. Lowering pressure 
in steps from 3 to 0.5 cmH2O resulted in a slowing of spontaneous contraction frequency 
and an increase in contraction amplitude at 1 and 2 cmH2O but a decrease in amplitude 
at 0.5 cmH2O; raising pressure from 0.5 to 10 cmH2O resulted in an increase in 
frequency and decrease in amplitude such that only weak contractions were observed at 
pressures higher than 5 cmH2O. Exposure of the vessel to 185 Na+ Krebs solution 
produced increases in frequency and slight decreases in amplitude at all pressures (C).  
Summary of results from 5 vessels exposed to 145, 165 and 185 mmol Na+ Krebs 
solutions and solutions where additional Na+ has been replaced by urea. Values mean ± 
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